{"gene":"PBX1","run_date":"2026-06-10T05:19:53","timeline":{"discoveries":[{"year":1999,"finding":"Crystal structure (2.35 Å) of a ternary HoxB1-Pbx1-DNA complex revealed that the HoxB1 hexapeptide binds in a hydrophobic pocket in the Pbx1 homeodomain formed by a three-amino-acid insertion; Pbx1 contains an additional fourth alpha-helix C-terminal to the canonical homeodomain that contributes to hexapeptide binding and to stable Pbx1-DNA interaction.","method":"X-ray crystallography (2.35 Å resolution)","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — atomic-resolution crystal structure with functional validation, foundational mechanistic paper replicated by subsequent structural studies","pmids":["10052460"],"is_preprint":false},{"year":1999,"finding":"NMR studies showed that the fourth (C-terminal) alpha-helix of Pbx1 is unfolded in solution and folds only upon DNA binding; no conformational change was detected upon mixing Pbx1 with HoxB1 in the absence of DNA, suggesting DNA binding precedes or is required for stable Hox-Pbx1 complex assembly.","method":"Multidimensional NMR spectroscopy (1H, 15N, 13C)","journal":"Journal of Molecular Biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — NMR solution structure with functional mechanistic implication, consistent with and complementary to the crystal structure in PMID 10052460","pmids":["10448033"],"is_preprint":false},{"year":2003,"finding":"Crystal structure (1.9 Å) of a HoxA9-Pbx1-DNA ternary complex revealed that the posterior Hox hexapeptide adopts an altered conformation compared to anterior Hox complexes, and that residues in the N-terminal arm of the Hox homeodomain determine DNA sequence specificity via indirect contacts, providing a structural basis for anterior-posterior Hox binding specificity modulated by Pbx1.","method":"X-ray crystallography (1.9 Å), DNA-binding assays with wild-type and mutant proteins","journal":"Genes & Development","confidence":"High","confidence_rationale":"Tier 1 / Strong — atomic-resolution structure plus mutagenesis and binding assays in a single rigorous study","pmids":["12923056"],"is_preprint":false},{"year":1995,"finding":"The conserved pentapeptide motif (F/Y-P-W-M-R/K) located N-terminal to the Hox homeodomain is essential for cooperative DNA binding with Pbx1; point mutations at tryptophan and methionine abolished cooperativity; a wild-type pentapeptide peptide blocked cooperative binding and also stimulated Pbx1 DNA binding alone, establishing direct physical contact between the pentapeptide and Pbx1.","method":"In vitro DNA binding assays, point mutational analysis, competitive peptide inhibition","journal":"Molecular and Cellular Biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with mutagenesis and peptide competition, replicated across multiple Hox proteins","pmids":["7565734"],"is_preprint":false},{"year":1995,"finding":"Pbx1 (and E2A-Pbx1) binds DNA cooperatively with multiple Hox proteins (HoxA5, HoxB7, HoxB8, HoxC8, HoxD4) on the ATCAATCAA motif; cooperative binding required the homeodomain-dependent DNA-binding activity of both partners; in cotransfection assays HoxB8 suppressed E2A-Pbx1 transactivation.","method":"Electrophoretic mobility shift assay (EMSA), cotransfection/reporter assays","journal":"Molecular and Cellular Biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro binding reconstitution with multiple Hox partners plus functional reporter assays, replicated across labs","pmids":["7791786"],"is_preprint":false},{"year":1996,"finding":"The Pbx1 homeodomain is sufficient for cooperative DNA binding with pentapeptide-containing Hox proteins; a 25-residue predicted alpha-helix preceding the homeodomain inhibits Pbx1 DNA binding and Hox heterodimerization, and a sequence immediately C-terminal to the homeodomain (highly conserved, predicted alpha-helix) enhances monomeric DNA binding and cooperativity; heterodimerization places Pbx1 on the 5' TTGAT core and Hox on the adjacent 3' TGAT core.","method":"In vitro DNA binding assays with deletion and chimeric mutants","journal":"Molecular and Cellular Biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — systematic in vitro mutagenesis and domain-mapping with reconstitution, single lab but multiple constructs","pmids":["8657138"],"is_preprint":false},{"year":1997,"finding":"Meis1 and pKnox1 dimerize with Pbx1 on a TGATTGAC motif; the Meis1/pKnox1-interaction domain in Pbx1 resides predominantly in a conserved N-terminal Pbx domain that is deleted in E2A-Pbx1, explaining why Meis1/pKnox1 fail to bind E2A-Pbx1; HPIP (a novel protein) also interacts with Pbx1 through the homeodomain and flanking sequences and inhibits PBX-HOX heterodimer DNA binding.","method":"EMSA, co-immunoprecipitation, yeast two-hybrid","journal":"PNAS","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal binding assays, domain-deletion mapping, and functional EMSA inhibition; replicated in part by PMID 10825160","pmids":["9405651"],"is_preprint":false},{"year":2000,"finding":"A novel protein HPIP (hematopoietic PBX-interacting protein) was identified by yeast two-hybrid as a Pbx1 interactor; HPIP is mainly cytosolic; it interacts with Pbx1 via the homeodomain and flanking sequences; HPIP inhibits PBX-HOX heterodimer DNA binding in EMSA and strongly inhibits E2A-PBX1 transactivation.","method":"Yeast two-hybrid, EMSA, transactivation reporter assays, subcellular fractionation","journal":"Journal of Biological Chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — yeast two-hybrid plus functional EMSA and reporter assay, single lab","pmids":["10825160"],"is_preprint":false},{"year":1999,"finding":"An inhibitory 25-residue alpha-helix immediately N-terminal to the Pbx1 homeodomain binds the homeodomain and prevents DNA binding and Hox heterodimerization; an additional 39-residue region N-terminal to this helix mediates Pbx homodimerization and heterodimerization on DNA; Hox and Meis1/Prep1 partners relieve the inhibitory switch; the inhibitory switch is dispensable for myeloid immortalization by E2A-Pbx1.","method":"In vitro DNA binding assays, deletion mutagenesis, myeloid immortalization assays","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with systematic mutagenesis, single lab","pmids":["10637514"],"is_preprint":false},{"year":1997,"finding":"Pbx1 heterodimers with different Hox proteins bind distinct DNA motifs; unique sequences in the N-terminal arm of the Hox homeodomain mediate this differential specificity; in vivo, Hox proteins directed E2A-Pbx1-mediated transactivation to cognate Hox-Pbx motifs, demonstrating Hox-dependent targeting of Pbx1 complexes to distinct genomic sites.","method":"EMSA with recombinant proteins, cotransfection/reporter assays, structural modeling","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro binding assays plus in vivo reporter assays with mutants, single lab","pmids":["9010234"],"is_preprint":false},{"year":1993,"finding":"Expression of the E2A-PBX1 chimeric homeodomain protein under control of the immunoglobulin heavy chain enhancer in transgenic mice induced T-cell lymphomas and paradoxically increased both cell cycling and apoptosis in pretumorous lymphoid cells, establishing that the fusion oncogene simultaneously drives proliferation and programmed cell death in lymphoid cells in vivo.","method":"Transgenic mouse model, flow cytometry, histopathology","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean transgenic in vivo loss-of-function model with defined cellular phenotypes, replicated by later conditional mouse models","pmids":["8104101"],"is_preprint":false},{"year":2001,"finding":"Pbx1-deficient mice die at E15/16 with widespread skeletal patterning defects restricted to Hox-dimerization-motif-bearing protein domains; in affected limbs and ribs, chondrocyte proliferation was markedly reduced with premature hypertrophy and precocious Col1a1 expression, establishing Pbx1 as a regulator of chondrocyte proliferation/differentiation timing without altering Hox gene expression.","method":"Pbx1 knockout mouse, histology, in situ hybridization, molecular marker analysis","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean constitutive knockout with detailed molecular and cellular phenotyping, widely replicated","pmids":["11566859"],"is_preprint":false},{"year":2002,"finding":"Pbx1-deficient embryos display pancreatic hypoplasia with severe defects in exocrine and endocrine cell differentiation; expression of Isl1 and Atoh5 was severely reduced; compound Pbx1+/−;Ipf1+/− mice develop overt diabetes, establishing in vivo genetic interaction between Pbx1 and Ipf1 (Pdx1) required for postnatal pancreatic function.","method":"Pbx1 knockout mouse, compound heterozygous mouse genetics (epistasis), molecular marker analysis, glucose tolerance testing","journal":"Nature Genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — constitutive and trans-heterozygous genetic epistasis with detailed molecular phenotyping","pmids":["11912494"],"is_preprint":false},{"year":2003,"finding":"Pbx1-deficient mice completely lack adrenal glands; expression of steroidogenic factor-1 (SF-1) was reduced to minimal levels in Pbx1 mutant genital ridges, placing Pbx1 upstream of SF-1 in the adrenocortical development pathway; loss of Pbx1 also impaired Müllerian duct formation and mesonephric differentiation.","method":"Pbx1 knockout mouse, molecular marker analysis (SF-1 expression), histology","journal":"Genesis","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean constitutive knockout with defined upstream pathway placement via molecular marker","pmids":["14595835"],"is_preprint":false},{"year":2003,"finding":"In Pbx1-deficient kidneys, ureteric branching and elongation were reduced and nephron number was decreased; heterologous recombination explant cultures demonstrated that renal defects arose exclusively from mesenchymal (not ureteric) dysfunction, establishing Pbx1 as a regulator of mesenchymal-epithelial signaling during renal morphogenesis.","method":"Pbx1 knockout mouse, kidney explant heterologous recombination assays, molecular marker analysis","journal":"Developmental Biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — clean knockout with tissue-specific rescue/chimera assay localizing defect to mesenchyme","pmids":["12591246"],"is_preprint":false},{"year":2005,"finding":"ChIP assays showed that Pbx1 binds the Hox11 promoter in spleen mesenchymal cells; Hox11 and Nkx2.5 expression are absent in Pbx1-null splenic anlage; Pbx1 and Hox11 genetically interact in spleen formation (double mutants have exacerbated phenotypes), establishing Pbx1 as a hierarchical upstream regulator in a Pbx1-Hox11 transcriptional pathway for spleen ontogeny.","method":"Pbx1/Hox11 double mutant mouse genetics, ChIP, in situ hybridization","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis combined with direct ChIP occupancy of target promoter","pmids":["15944191"],"is_preprint":false},{"year":2006,"finding":"Pbx1/Pbx2 compound loss-of-function mice exhibit severe distal limb defects and Pbx1−/−;Pbx2−/− embryos lack limbs entirely; these defects are mediated by hierarchical control of Hox gene spatial distribution and Shh expression in the posterior limb/ZPA, demonstrating that Pbx1/Pbx2 act upstream of Hox genes and Shh to control limb axis patterning.","method":"Pbx1/Pbx2 double knockout mouse, in situ hybridization, molecular marker analysis","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 / Strong — compound knockout with molecular epistasis placing Pbx1/2 upstream of Hox and Shh","pmids":["16672333"],"is_preprint":false},{"year":2008,"finding":"Pbx1/Pbx2 compound loss-of-function establishes that axial skeletal patterning requires Pbx1/2 through genetic control of Polycomb and Hox expression in mesoderm and Pax1/Pax9 expression in sclerotome, placing Pbx1/2 in a hierarchical position above these axial patterning regulators.","method":"Pbx1/Pbx2 double knockout mouse, molecular marker analysis (Polycomb, Hox, Pax1/Pax9)","journal":"Developmental Biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — compound knockout with molecular epistasis, single lab","pmids":["18691704"],"is_preprint":false},{"year":2007,"finding":"Using Rag1-deficient blastocyst complementation, Pbx1-null ES cells failed to generate common lymphoid progenitors (CLPs), resulting in complete absence of B and NK cells and partial impairment of T-cell development; restoration of Pbx1 expression rescued B-cell development from CLPs; conditional inactivation in pro-B (CD19+) cells showed Pbx1 is not required after CLP commitment, placing its essential function between HSC and CLP stages.","method":"Blastocyst complementation (Rag1-deficient), conditional gene rescue, adoptive transfer, flow cytometry","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple complementary in vivo approaches (complementation + rescue + conditional KO) placing Pbx1 function at specific developmental stage","pmids":["17244677"],"is_preprint":false},{"year":2009,"finding":"Pbx1 is a direct transcriptional target of Evi-1; Evi-1 overexpression upregulates Pbx1 transcription via the Pbx1 promoter; RNAi knockdown of Pbx1 inhibits Evi-1-induced bone marrow transformation but not transformation by E2A/HLF or AML1/ETO, establishing Pbx1 as specifically required downstream of Evi-1 in leukemogenesis.","method":"Promoter reporter assays, RNAi knockdown, bone marrow transformation assays, genetic epistasis","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — promoter analysis plus functional epistasis via RNAi, single lab","pmids":["19767769"],"is_preprint":false},{"year":2009,"finding":"KLF4 and PBX1 are transcriptional activators of NANOG in human ESCs; PBX1 binds directly to a novel upstream enhancer and the proximal NANOG promoter (confirmed by ChIP and EMSA); knockdown or mutation of PBX1 binding sites reduces NANOG promoter activity; PBX1 cooperates synergistically with OCT4 and SOX2 to transactivate NANOG.","method":"ChIP, EMSA, luciferase reporter assay, RNAi knockdown, overexpression in hESCs","journal":"Stem Cells","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct binding confirmed by ChIP and EMSA plus functional reporter assays, single lab","pmids":["19522013"],"is_preprint":false},{"year":2010,"finding":"Pbx1 negatively regulates Hoxa10-mediated osteoblast gene transcription; ChIP showed Pbx1 is associated with histone deacetylases (HDACs) at osteoblast-related gene promoters; loss of Pbx1 from promoters during differentiation correlates with increased histone acetylation, CBP/p300 recruitment, and decreased H3K9 methylation; Pbx1 acts through a Pbx-binding site that attenuates Hoxa10-mediated activation of osteocalcin and Bsp promoters.","method":"ChIP, shRNA knockdown, reporter assays with wild-type and mutant promoters, overexpression in mesenchymal cells","journal":"Molecular and Cellular Biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus functional reporter assays and knockdown, single lab","pmids":["20439491"],"is_preprint":false},{"year":2011,"finding":"PBX1 acts as a pioneer factor in breast cancer cells: ChIP-seq and FAIRE-seq showed PBX1 is loaded at specific genomic locations with open chromatin, promotes chromatin accessibility, reads specific epigenetic signatures, and guides ERα recruitment to a specific subset of genomic sites; PBX1 depletion abolishes estrogen-stimulated proliferation and controls >70% of the estrogen transcriptional response.","method":"ChIP-seq, FAIRE-seq, shRNA knockdown, expression profiling","journal":"PLoS Genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — genome-wide ChIP-seq plus chromatin accessibility (FAIRE-seq) plus functional knockdown, multiple orthogonal methods","pmids":["22125492"],"is_preprint":false},{"year":2012,"finding":"GCN5 (acetyltransferase subunit of the STAGA complex) directly interacts with the E2A portion of E2A-PBX1, acetylates E2A-PBX1, and increases its protein stability in cells; the E3 ubiquitin ligase HDM2 promotes E2A-PBX1 degradation; GCN5 inhibitor MB-3 decreases E2A-PBX1 acetylation and protein levels in leukemic cells.","method":"Co-immunoprecipitation, in vitro/cell-based acetylation assays, Western blot, pharmacological inhibition","journal":"Leukemia","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP and biochemical acetylation assays, single lab","pmids":["23044487"],"is_preprint":false},{"year":2012,"finding":"Structural determination of the E2A PCET motif bound to the KIX domain of CBP/p300; residues throughout the helical PCET motif contact KIX; these residues are required for both KIX binding and bone marrow immortalization by E2A-PBX1, establishing the PCET/KIX interaction as mechanistically required for E2A-PBX1 leukemogenic activity.","method":"NMR/X-ray structural determination of peptide-KIX complex, mutagenesis, bone marrow immortalization assay","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1 / Moderate — structure plus mutagenesis plus functional assay in one study, single lab","pmids":["22972988"],"is_preprint":false},{"year":2005,"finding":"Pbx1 binds Hoxb1 autoregulatory enhancer elements (PH and PM sites); Prep1-Pbx1 forms ternary complexes with Hoxb1 at the R3/PM2 combination sufficient to drive hindbrain r4 reporter expression in vivo; a high-affinity PM site (R2/PM3) inhibits ternary complex formation and restricts reporter expression, demonstrating that multiple Prep1-Pbx1 and Pbx1-Hox binding sites cooperate to modulate Hoxb1 autoregulation.","method":"In vitro binding assays, transgenic reporter analysis in chick and mouse embryos, mutagenesis of binding sites","journal":"Molecular and Cellular Biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — binding assays plus in vivo transgenic reporter with mutagenesis, single lab","pmids":["16166636"],"is_preprint":false},{"year":2008,"finding":"Pbx1 is a direct transcriptional target of Notch3; the Notch3/CSL protein complex binds directly to the CSL-binding sequence in the Pbx1 promoter; ectopic Pbx1 expression partially reverses the growth-inhibitory effect of gamma-secretase inhibitor; Pbx1 shRNA knockdown reduces cell proliferation and tumorigenicity in ovarian cancer cells.","method":"ChIP (Notch3/CSL-Pbx1 promoter), reporter assay, shRNA knockdown, rescue experiment with ectopic expression","journal":"Cancer Research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct promoter binding by ChIP plus functional rescue experiment, single lab","pmids":["18974129"],"is_preprint":false},{"year":2014,"finding":"Prep1 and Meis1 competitively heterodimerize with Pbx1; Prep1 posttranslationally reduces Meis1 stability by sequestering Pbx1 from Meis1; loss of Prep1 allows Meis1 to remain bound to Pbx1 and remain stable, enabling oncogenic transformation; Pbx1 can therefore function as either oncogene or tumor suppressor depending on which partner (Meis1 vs. Prep1) it dimerizes with.","method":"Co-immunoprecipitation, protein stability assays, transformation assays in mouse embryonic fibroblasts, overexpression/knockdown","journal":"PNAS","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP plus protein stability and transformation assays, single lab","pmids":["24578510"],"is_preprint":false},{"year":2016,"finding":"PBX1 directly represses Onecut2 (to inhibit lateral fates) and directly activates Pitx3 (to promote mDAn development) and Nfe2l1 (to protect from oxidative stress) in midbrain dopaminergic neurons; PBX1 and NFE2L1 levels are severely reduced in dopaminergic neurons of the substantia nigra in Parkinson's disease patients.","method":"ChIP, conditional knockout mouse (loss of function), gene expression analysis, human PD tissue analysis","journal":"The EMBO Journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus conditional KO with defined gene targets, single lab","pmids":["27354364"],"is_preprint":false},{"year":2016,"finding":"PBX1 directly binds the STAT3 promoter and positively regulates STAT3 transcription in ovarian cancer; silencing PBX1 in platinum-resistant cells reduces stem-like properties and sensitizes cells to carboplatin; a STAT3/JAK2 inhibitor potently sensitizes platinum-resistant cells to carboplatin in vivo.","method":"ChIP, shRNA knockdown, overexpression, in vivo xenograft model","journal":"Cancer Research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct ChIP binding plus functional knockdown/rescue assays, single lab","pmids":["27590741"],"is_preprint":false},{"year":2016,"finding":"Pbx1-d (dominant-negative isoform lacking DNA-binding and Hox-binding domains) expression in CD4+ T cells expands follicular helper T cells (TFH) and impairs Foxp3+ Treg homeostasis; Pbx1-d-Tg CD4+ T cells upregulate miR-10a, miR-21, and miR-155; Pbx1-d directly regulates CD44 expression through two promoter binding sites, with enhanced MEIS co-factor recruitment relative to normal Pbx1-b.","method":"Transgenic mouse model, flow cytometry, ChIP, reporter assay, co-factor recruitment assay","journal":"Journal of Immunology / Molecular Immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — transgenic mouse plus ChIP and co-factor assays, single lab across two papers","pmids":["27296664","28257976"],"is_preprint":false},{"year":2016,"finding":"Pbx1 restrains myeloid maturation and maintains lymphoid potential in multipotent progenitors; conditional Pbx1 knockout reduces MPP and CMP pools due to aberrantly rapid myeloid differentiation, associated with premature myeloid gene expression and reduced Meis1 expression (a Pbx1 dimerization partner), placing Pbx1 upstream of Meis1-dependent transcriptional programs in hematopoietic progenitor lineage specification.","method":"Conditional Pbx1 knockout mouse, flow cytometry of purified progenitors, transcriptional profiling, proliferation/differentiation assays","journal":"Journal of Cell Science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO with purified progenitor analysis and transcriptional profiling, single lab","pmids":["23660001"],"is_preprint":false},{"year":2016,"finding":"Pbx1 is required for adult subventricular zone (SVZ) neurogenesis; retroviral Cre-mediated deletion in Pbx2-deficient SVZ stem/progenitor cells significantly reduced neuron production and increased oligodendrocyte generation; loss of Pbx1 in neuroblasts compromised cell survival; ChIP from endogenous tissues detected PBX1 binding to regulatory regions of Dcx and Th weeks before their expression, suggesting a priming/pioneer role.","method":"Retroviral Cre delivery in conditional/Pbx2-null mice, neurosphere assays, ChIP from endogenous brain tissue","journal":"Development","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO with cell fate analysis plus direct ChIP occupancy, single lab","pmids":["27226325"],"is_preprint":false},{"year":2018,"finding":"SETDB2 is directly transcriptionally activated by E2A-PBX1 in pre-BCR+ ALL and suppresses expression of cell-cycle inhibitor CDKN2C through histone H3K9 tri-methylation, establishing an oncogenic pathway subordinate to E2A-PBX1 that silences a tumor suppressor.","method":"ChIP, shRNA knockdown, H3K9me3 ChIP, in vitro/in vivo leukemia maintenance assays","journal":"Cell Reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct ChIP binding of E2A-PBX1 to SETDB2 plus H3K9me3 ChIP on CDKN2C plus functional KD, single lab","pmids":["29694893"],"is_preprint":false},{"year":2019,"finding":"USP9x deubiquitinase interacts with PBX1 and stabilizes PBX1 protein by attenuating Lys48-linked polyubiquitination; USP9x inhibitor WP1130 induces PBX1 degradation and promotes prostate cancer cell apoptosis, identifying USP9x as a specific deubiquitinase for PBX1.","method":"Co-immunoprecipitation, ubiquitination assays, pharmacological inhibition (WP1130), siRNA knockdown, apoptosis assays","journal":"Journal of Biological Chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP plus biochemical ubiquitination assay plus functional rescue, single lab","pmids":["30718275"],"is_preprint":false},{"year":2019,"finding":"PBX1 promotes NK cell development by directly binding the Nfil3 promoter and upregulating NFIL3/E4BP4 transcription; conditional PBX1 knockout in hematopoietic cells reduces pre-NKP and rNKP progenitors similarly to NFIL3 deficiency; CRISPR knockout of the PBX1-binding site in the Nfil3 promoter in vivo reduces NK precursor and mature NK cells; asparagine N286 in the PBX1 homeodomain is required for Nfil3 promoter binding.","method":"Conditional knockout mouse, CRISPR-mediated binding-site deletion in vivo, ChIP, site-directed mutagenesis","journal":"FASEB Journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO plus in vivo CRISPR binding-site deletion plus ChIP plus homeodomain mutagenesis, multiple orthogonal approaches","pmids":["32190943"],"is_preprint":false},{"year":2019,"finding":"PBX1 expression in decidual NK (dNK) cells is upregulated through AKT1 pathway activation downstream of MHC-G/ILT2 receptor interaction; PBX1 drives pleiotrophin and osteoglycin transcription in dNK cells to promote fetal development; Pbx1 inactivation in mouse dNK cells impairs fetal development by reducing growth-promoting factors from CD49a+PBX1+ dNK cells.","method":"Conditional knockout mouse (dNK-specific), pathway inhibition, ChIP/transcriptional assays, human patient samples","journal":"Science Translational Medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO with defined target genes and upstream pathway, single lab","pmids":["32238574"],"is_preprint":false},{"year":2020,"finding":"E2A-PBX1 preferentially binds genomic loci co-occupied by RUNX1 and gene-activating machinery (p300, MED1, H3K27ac); E2A-PBX1 directly interacts with RUNX1 through the PBX1 homeodomain region; E2A-PBX1 chromatin binding at enhancers depends on the RUNX1 interaction but not on PBX1 homeodomain DNA-binding activity; RUNX1 is required for E2A-PBX1 target gene activation and leukemogenesis; E2A-PBX1 also directly activates the RUNX1 locus itself.","method":"ChIP-seq, co-immunoprecipitation, CRISPR/mutagenesis, transcriptome analysis, cell transformation assays","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — genome-wide ChIP-seq plus reciprocal co-IP plus mutagenesis plus functional leukemogenesis assay, multiple orthogonal methods","pmids":["32276273"],"is_preprint":false},{"year":2021,"finding":"Mediator subunit MED1 directly interacts with the E2A activation domain of E2A-PBX1; MED1 depletion by CRISPR/Cas9 specifically impairs E2A-PBX1-dependent gene activation and leukemic cell growth; DNA-bound RUNX1 recruits E2A-PBX1 to target loci and EBF1 further stabilizes this interaction, establishing a multi-factor complex required for E2A-PBX1 oncogenic transcription.","method":"Co-immunoprecipitation, CRISPR/Cas9 knockout, ChIP-seq, transcriptome analysis, in vitro binding assays","journal":"PNAS","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct binding assay plus CRISPR KO plus multi-omics, multiple orthogonal methods in one study","pmids":["33542097"],"is_preprint":false},{"year":2003,"finding":"Glucocorticoid receptor (GR) physically interacts with Pbx1 in vivo (co-immunoprecipitation); the GR DNA-binding domain is required for GC/RA synergy; GC potentiates RA-induced Hoxb-1 expression through the Pbx1/HOXB1-bound autoregulatory element b1-ARE without requiring GR binding to that element, suggesting GR-Pbx1 cross-talk regulates Hox target gene expression.","method":"Co-immunoprecipitation, reporter assays, domain-deletion analysis","journal":"Biochemical Journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP plus domain-deletion functional assay, single lab","pmids":["12487626"],"is_preprint":false},{"year":2007,"finding":"A novel zinc-finger protein ZFPIP physically binds PBX1 in vivo and prevents the binding of HOXA9/PBX1 complexes to their consensus DNA site, identifying a new class of PBX1 inhibitory partner that modulates Hox-PBX1 DNA binding.","method":"Yeast two-hybrid, co-immunoprecipitation, EMSA","journal":"Mechanisms of Development","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — yeast two-hybrid confirmed by co-IP plus functional EMSA inhibition, single lab","pmids":["17353115"],"is_preprint":false},{"year":2019,"finding":"A de novo missense mutation p.Arg235Gln in the TALE homeodomain nuclear localization signal of PBX1 impairs nuclear localization of the protein and abolishes its physical interaction with CBX2 and EMX2 (proteins required for testis-determination), providing a mechanism for 46,XY gonadal dysgenesis caused by this mutation.","method":"Subcellular localization assay, co-immunoprecipitation, patient mutation analysis","journal":"Human Mutation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct co-IP showing loss of interaction plus localization assay for patient mutation, single study","pmids":["31058389"],"is_preprint":false},{"year":2022,"finding":"METTL3-mediated m6A modification stabilizes PBX1 mRNA; PBX1 acts as a transcription factor inducing GCH1 expression (confirmed by ChIP); the METTL3-PBX1-GCH1 axis increases tetrahydrobiopterin (BH4) levels in gastric cancer cells to promote tumor progression.","method":"m6A RIP-seq, ChIP, Western blot, xenograft model, ELISA/LC-MS","journal":"Cancer Communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP confirmation of direct PBX1-GCH1 promoter binding plus in vivo xenograft, single lab","pmids":["35261206"],"is_preprint":false},{"year":2022,"finding":"PBX1 is ectopically expressed in chr1q-amplified multiple myeloma via amplification and epigenetic activation of its 3D regulatory domain; PBX1 binds to reprogrammed superenhancers and directly regulates a FOXM1-dependent transcriptional program; pharmacological disruption with T417 (a novel PBX1 small molecule inhibitor docking to the PBX1-DNA interface) is selectively toxic to chr1q-amp myeloma and solid tumor cells.","method":"Multi-omics (ChIP-seq, 3D chromatin), pharmacological inhibition (T417/thiostrepton), patient genomic data integration","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP-seq showing direct PBX1-superenhancer binding plus functional inhibitor with selective toxicity, single lab","pmids":["35015835"],"is_preprint":false},{"year":2023,"finding":"Pbx1 directly regulates B-cell homeostasis by targeting proliferation and apoptosis pathway genes; B cell-specific Pbx1 knockout in mice causes excessive humoral responses and enhanced germinal center reactions; ChIP and CUT&TAG assays identified direct Pbx1 target genes controlling B-cell survival and proliferation; enforced PBX1 expression in SLE patient B cells attenuates their survival and proliferative capacity.","method":"B cell-specific conditional knockout mouse, ChIP, CUT&TAG, RNA-seq, overexpression in human SLE B cells","journal":"Arthritis & Rheumatology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO with CUT&TAG direct binding plus human cell functional validation, single lab","pmids":["36862399"],"is_preprint":false},{"year":2023,"finding":"PBX1/2 and HAND2 cooperate to direct a limb-specific gene regulatory network (GRN) in posterior hindlimb mesenchymal cells; tissue-specific and temporally controlled mutagenesis combined with genome-wide PBX1 binding profiling across multiple embryonic tissues shows that HAND2 interacts with subsets of PBX1-bound regions to restrict PBX1 activity to limb-specific GRNs, explaining how ubiquitous PBX1 achieves tissue-specific functions.","method":"Conditional/temporal knockout mouse, multi-omics (ChIP-seq across tissues, ATAC-seq), co-immunoprecipitation/interaction assays","journal":"Nature Communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — tissue-specific KO with genome-wide PBX1 binding profiling across multiple tissues plus interaction assays, multiple orthogonal methods","pmids":["37414772"],"is_preprint":false},{"year":2023,"finding":"TRIM26 E3 ubiquitin ligase binds PBX1 (identified by affinity purification-MS) and mediates K48-linked polyubiquitination and proteasomal degradation of PBX1 in a RING domain-dependent manner; TRIM26 inhibits PBX1 transcriptional activity and downregulates PBX1 target gene RNF6.","method":"Affinity purification-MS, co-immunoprecipitation, ubiquitination assay, domain deletion (RING), reporter assay, xenograft model","journal":"International Journal of Biological Sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — AP-MS identification confirmed by co-IP plus biochemical ubiquitination assay with domain deletion, single lab","pmids":["37324936"],"is_preprint":false},{"year":1996,"finding":"An internal domain of Pbx1 (upstream of the homeodomain, highly conserved among Pbx proteins) selectively represses transcription induced by the Sp1 activation domain but not VP16 or p53, and this repression activity does not require homeodomain-dependent DNA binding, indicating Pbx1 can regulate transcription through DNA-binding-independent mechanisms.","method":"Transient transfection reporter assays, domain-deletion analysis","journal":"PNAS","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — functional reporter assays with systematic domain deletions, single lab, no direct binding partner identified","pmids":["8552663"],"is_preprint":false},{"year":2021,"finding":"PBX1 is required for MPN progression driven by JAK2V617F; in compound JAK2V617F × Pbx1-null mice (JP model), typical MPN features (thrombocythemia, granulocytosis, splenomegaly, cytokine-independent growth) are absent; PBX1 controls part of the molecular pathways deregulated by JAK2V617F, placing PBX1 as a required co-effector downstream or parallel to JAK2V617F signaling in MPN.","method":"Conditional double-mutant mouse model (JAK2V617F × Pbx1 knockout), flow cytometry, transcriptome profiling","journal":"Stem Cell Reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — compound genetic model with transcriptomic analysis demonstrating pathway co-dependence, single lab","pmids":["34678207"],"is_preprint":false}],"current_model":"PBX1 is a TALE-class homeodomain transcription factor that forms heterodimeric and trimeric complexes with HOX proteins (via hexapeptide-homeodomain pocket interaction), MEIS/PREP1 family members (via a conserved N-terminal domain deleted in E2A-PBX1), and a growing repertoire of non-homeodomain partners (HAND2, RUNX1, GR, CBX2, EMX2, ZFPIP, HPIP); its DNA-binding activity is controlled by an autoinhibitory helix derepressed upon partner binding; it functions as a pioneer factor that opens chromatin and guides binding of ERα and other transcription factors to specific genomic loci; it acts hierarchically upstream of HOX genes, Shh, Polycomb, and multiple organ-specific regulators (SF-1, Nkx2.5/Hox11, NFIL3, Pitx3) to coordinate cell proliferation, differentiation, and organ morphogenesis; and its stability is regulated post-translationally by USP9x-mediated deubiquitination and TRIM26-mediated K48-polyubiquitination for proteasomal degradation, while the oncogenic fusion E2A-PBX1 is acetylated and stabilized by GCN5 and recruits CBP/p300 (via PCET/KIX interaction) and MED1/Mediator to drive leukemic transcriptional programs dependent on co-recruitment of RUNX1."},"narrative":{"mechanistic_narrative":"PBX1 is a TALE-class homeodomain transcription factor that acts as a hierarchical master regulator of cell proliferation, differentiation, and organ morphogenesis by forming cooperative DNA-binding complexes with partner proteins [PMID:16672333, PMID:11566859]. Its homeodomain contains a three-residue insertion that creates a hydrophobic pocket binding the conserved hexapeptide/pentapeptide motif of HOX partners, and an additional C-terminal alpha-helix—unfolded in solution and folded only upon DNA binding—that stabilizes the Pbx-DNA interface [PMID:10052460, PMID:10448033, PMID:7565734]. Heterodimerization positions PBX1 on the 5' TTGAT core adjacent to the HOX 3' site, while the identity of the HOX partner dictates target-site specificity and thereby the genomic loci of the complex [PMID:8657138, PMID:9010234, PMID:12923056]. DNA binding is governed by an autoinhibitory N-terminal alpha-helix that occludes the homeodomain and is derepressed upon binding of HOX or MEIS/PREP1 partners, the latter engaging a conserved N-terminal Pbx domain [PMID:10637514, PMID:9405651]. PBX1 functions as a pioneer factor that loads at specific loci, opens chromatin, reads epigenetic signatures, and guides recruitment of partner transcription factors such as ERα [PMID:22125492], and it occupies target regulatory regions prior to gene activation during neurogenesis [PMID:27226325]. Genetically, PBX1 sits upstream of HOX genes, Shh, Polycomb, and organ-specific regulators (SF-1, Hox11/Nkx2.5, Pitx3, NFIL3) to control skeletal, limb, pancreatic, adrenal, renal, hematopoietic, and neuronal development [PMID:16672333, PMID:14595835, PMID:11912494, PMID:11566859, PMID:15944191, PMID:27354364, PMID:32190943]; tissue-restricted partners such as HAND2 confine ubiquitous PBX1 activity to lineage-specific gene regulatory networks [PMID:37414772]. PBX1 protein stability is set by opposing post-translational modifiers: USP9x deubiquitinates and stabilizes PBX1, whereas TRIM26 mediates K48-linked polyubiquitination and proteasomal degradation [PMID:30718275, PMID:37324936]. The oncogenic E2A-PBX1 fusion, which lacks the MEIS-interaction domain, drives leukemic transcription through RUNX1-dependent chromatin co-occupancy and recruitment of CBP/p300 (via the PCET/KIX interaction) and MED1/Mediator [PMID:32276273, PMID:33542097, PMID:22972988]. A de novo p.Arg235Gln mutation in the homeodomain nuclear localization signal causes 46,XY gonadal dysgenesis by impairing nuclear localization and CBX2/EMX2 binding [PMID:31058389].","teleology":[{"year":1995,"claim":"Established the molecular basis of cooperative HOX-PBX1 DNA binding, answering how two homeodomain proteins achieve combinatorial specificity neither has alone.","evidence":"In vitro DNA-binding assays, point mutagenesis, and peptide competition across multiple HOX proteins on the ATCAATCAA motif","pmids":["7565734","7791786"],"confidence":"High","gaps":["Did not resolve the structural geometry of the contact","In vivo target genes not yet defined"]},{"year":1996,"claim":"Mapped PBX1 functional domains, showing the homeodomain suffices for cooperativity, that an N-terminal helix autoinhibits DNA binding, and that PBX1 can also repress transcription independent of DNA binding.","evidence":"Domain-deletion and chimeric mutagenesis with in vitro binding and reporter assays","pmids":["8657138","8552663"],"confidence":"High","gaps":["Mechanism of DNA-binding-independent repression had no identified partner","Physiological derepression trigger not defined"]},{"year":1997,"claim":"Defined the second partner class (MEIS1/PREP1) and the domain mediating it, explaining why the oncogenic E2A-PBX1 fusion cannot bind MEIS and identifying inhibitory partner HPIP.","evidence":"EMSA, co-IP, yeast two-hybrid with domain-deletion mapping","pmids":["9405651","9010234"],"confidence":"High","gaps":["Did not establish the in vivo consequence of MEIS vs HOX partner choice","HPIP regulation of PBX1 not yet functionally validated in vivo"]},{"year":1999,"claim":"Provided the atomic and dynamic structural mechanism: a homeodomain insertion forms the hexapeptide pocket and a fourth helix folds only upon DNA binding, ordering complex assembly.","evidence":"X-ray crystallography of HoxB1-Pbx1-DNA and multidimensional NMR of Pbx1","pmids":["10052460","10448033"],"confidence":"High","gaps":["Did not address posterior HOX complexes","Autoinhibitory helix geometry resolved only later"]},{"year":1999,"claim":"Resolved the autoinhibitory switch as a discrete N-terminal helix occluding the homeodomain, relieved by HOX and MEIS/PREP1 partners, and showed it is dispensable for E2A-PBX1 immortalization.","evidence":"In vitro deletion mutagenesis plus myeloid immortalization assays","pmids":["10637514"],"confidence":"Medium","gaps":["Single lab in vitro mapping","How partner binding mechanically displaces the helix not shown"]},{"year":2003,"claim":"Extended the structural model to posterior HOX, showing N-terminal arm residues confer differential DNA specificity, providing a structural basis for anterior-posterior HOX selectivity modulated by PBX1.","evidence":"1.9 Å crystal structure of HoxA9-Pbx1-DNA with mutant binding assays","pmids":["12923056"],"confidence":"High","gaps":["Did not map specificity onto in vivo genomic occupancy"]},{"year":2003,"claim":"Demonstrated PBX1 as an essential hierarchical organ-patterning factor across multiple organ systems, placing it genetically upstream of organ-specific regulators.","evidence":"Constitutive and compound-heterozygous mouse knockouts with marker analysis, explant recombination, and glucose-tolerance phenotyping (skeleton, pancreas/Ipf1, adrenal/SF-1, kidney mesenchyme)","pmids":["11566859","11912494","14595835","12591246"],"confidence":"High","gaps":["Direct promoter occupancy at most downstream targets not shown in these studies","Did not distinguish HOX-dependent vs HOX-independent mechanisms per organ"]},{"year":2006,"claim":"Established that PBX1/PBX2 act upstream of HOX, Shh, and Polycomb to control limb and axial patterning, demonstrating their hierarchical position above these regulators.","evidence":"Pbx1/Pbx2 compound knockout mice with in situ hybridization and molecular markers","pmids":["16672333","18691704","15944191"],"confidence":"High","gaps":["Mechanism of redundancy between PBX1 and PBX2 not fully separated","Direct vs indirect control of Shh/Polycomb not resolved"]},{"year":2011,"claim":"Defined PBX1 as a stage-specific hematopoietic regulator required between HSC and common lymphoid progenitor stages, controlling lymphoid potential and restraining myeloid maturation via MEIS1-dependent programs.","evidence":"Blastocyst complementation, conditional knockout, rescue, and progenitor profiling","pmids":["17244677","23660001"],"confidence":"High","gaps":["Direct PBX1 target genes in progenitors not fully enumerated","Partner requirements at each stage not dissected"]},{"year":2012,"claim":"Discovered PBX1 functions as a pioneer factor that opens chromatin and guides ERα recruitment, redefining it from a passive HOX cofactor to a primary determinant of chromatin accessibility and the estrogen transcriptional response.","evidence":"ChIP-seq, FAIRE-seq, and shRNA knockdown with expression profiling in breast cancer cells","pmids":["22125492"],"confidence":"High","gaps":["Determinants of locus selection by PBX1 not fully defined","Whether pioneer activity requires partner proteins not resolved here"]},{"year":2014,"claim":"Showed PBX1 can be oncogene or tumor suppressor depending on partner choice, because PREP1 sequesters PBX1 from MEIS1 and destabilizes MEIS1, linking partner competition to transformation.","evidence":"Co-IP, protein-stability assays, and transformation assays in mouse embryonic fibroblasts","pmids":["24578510"],"confidence":"Medium","gaps":["Single-lab biochemistry","Quantitative thresholds of partner availability in vivo unknown"]},{"year":2016,"claim":"Established direct PBX1 transcriptional control of lineage-specifying genes across diverse contexts (NK cells, dopaminergic neurons, SVZ neurogenesis, T-cell tolerance), including occupancy of regulatory regions before target expression consistent with a priming role.","evidence":"Conditional knockouts, transgenics, and ChIP at Nfil3, Pitx3/Onecut2/Nfe2l1, Dcx/Th, and CD44 with human PD tissue analysis","pmids":["27354364","27226325","32190943","27296664","28257976"],"confidence":"Medium","gaps":["Mechanism of temporal priming not biochemically defined","Most targets validated in single systems"]},{"year":2020,"claim":"Defined the E2A-PBX1 leukemic transcription mechanism as RUNX1-dependent chromatin tethering coupled to coactivator recruitment, rather than dependence on the PBX1 homeodomain DNA-binding activity.","evidence":"ChIP-seq, reciprocal co-IP, CRISPR/mutagenesis, and transformation assays defining RUNX1, p300/CBP (PCET/KIX), and MED1/Mediator dependence","pmids":["32276273","33542097","22972988","23044487","29694893"],"confidence":"High","gaps":["Stoichiometry of the multi-factor enhancer complex not resolved","Whether wild-type PBX1 uses analogous coactivator recruitment unclear"]},{"year":2023,"claim":"Explained how a ubiquitous factor achieves tissue specificity: tissue-restricted partners such as HAND2 occupy subsets of PBX1-bound regions to channel PBX1 into limb-specific gene regulatory networks.","evidence":"Tissue-specific/temporal knockout with genome-wide PBX1 binding across multiple tissues, ATAC-seq, and interaction assays","pmids":["37414772"],"confidence":"High","gaps":["Generality of partner-restricted targeting beyond limb not tested","Direct structural basis of HAND2-PBX1 contact not shown"]},{"year":2023,"claim":"Identified the post-translational control of PBX1 abundance as a tunable opposing pair of enzymes, linking ubiquitin homeostasis to PBX1-driven transcriptional output.","evidence":"Co-IP/AP-MS, ubiquitination assays, domain deletion, and pharmacological inhibition (USP9x stabilizing; TRIM26 K48-degrading)","pmids":["30718275","37324936"],"confidence":"Medium","gaps":["Upstream signals controlling USP9x/TRIM26 activity on PBX1 unknown","Modification sites on PBX1 not mapped"]},{"year":null,"claim":"How wild-type PBX1 pioneer activity, partner-dictated locus selection, and post-translational stability are integrated to produce context-specific transcriptional outputs in vivo remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model linking chromatin opening to partner choice","Determinants of genome-wide site selection by free PBX1 undefined","Therapeutic targeting of the PBX1-DNA interface remains early-stage"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,3,4,5,9]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[22,28,29,35,47]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[41]},{"term_id":"GO:0005654","term_label":"nucleoplasm","supporting_discovery_ids":[22,37]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[22,35,37,45]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[11,12,13,14,16]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[22,32]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[10,37,38,41]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[18,35,44]}],"complexes":["PBX1-HOX heterodimer","PREP1/MEIS1-PBX1-HOX ternary complex"],"partners":["HOXB1","HOXA9","MEIS1","PREP1/PKNOX1","RUNX1","HAND2","USP9X","TRIM26"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P40424","full_name":"Pre-B-cell leukemia transcription factor 1","aliases":["Homeobox protein PBX1","Homeobox protein PRL"],"length_aa":430,"mass_kda":46.6,"function":"Transcription factor which binds the DNA sequence 5'-TGATTGAT-3' as part of a heterodimer with HOX proteins such as HOXA1, HOXA5, HOXB7 and HOXB8 (PubMed:9191052). Binds to the DNA sequence 5'-TGATTGAC-3' in complex with a nuclear factor which is not a class I HOX protein (PubMed:9191052). Has also been shown to bind the DNA sequence 5'-ATCAATCAA-3' cooperatively with HOXA5, HOXB7, HOXB8, HOXC8 and HOXD4 (PubMed:7791786, PubMed:8327485). Acts as a transcriptional activator of PF4 in complex with MEIS1 (PubMed:12609849). Also activates transcription of SOX3 in complex with MEIS1 by binding to the 5'-TGATTGAC-3' consensus sequence (By similarity). In natural killer cells, binds to the NFIL3 promoter and acts as a transcriptional activator of NFIL3, promoting natural killer cell development (By similarity). Plays a role in the cAMP-dependent regulation of CYP17A1 gene expression via its cAMP-regulatory sequence (CRS1) (By similarity). Probably in complex with MEIS2, involved in transcriptional regulation by KLF4 (PubMed:21746878). Acts as a transcriptional activator of NKX2-5 and a transcriptional repressor of CDKN2B (By similarity). Together with NKX2-5, required for spleen development through a mechanism that involves CDKN2B repression (By similarity) As part of a PDX1:PBX1b:MEIS2B complex in pancreatic acinar cells, is involved in the transcriptional activation of the ELA1 enhancer; the complex binds to the enhancer B element and cooperates with the transcription factor 1 complex (PTF1) bound to the enhancer A element","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/P40424/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PBX1","classification":"Not Classified","n_dependent_lines":10,"n_total_lines":1208,"dependency_fraction":0.008278145695364239},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"HDAC1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/PBX1","total_profiled":1310},"omim":[{"mim_id":"618819","title":"PBX HOMEOBOX-INTERACTING PROTEIN 1; PBXIP1","url":"https://www.omim.org/entry/618819"},{"mim_id":"617641","title":"CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED","url":"https://www.omim.org/entry/617641"},{"mim_id":"617371","title":"ZINC FINGER PROTEIN 462; ZNF462","url":"https://www.omim.org/entry/617371"},{"mim_id":"613066","title":"PBX/KNOTTED 1 HOMEOBOX 2; PKNOX2","url":"https://www.omim.org/entry/613066"},{"mim_id":"612666","title":"DUAL SERINE/THREONINE AND TYROSINE PROTEIN KINASE; DSTYK","url":"https://www.omim.org/entry/612666"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Nuclear bodies","reliability":"Additional"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/PBX1"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P40424","domains":[{"cath_id":"-","chopping":"102-117_144-234","consensus_level":"high","plddt":90.0587,"start":102,"end":234},{"cath_id":"1.10.10.60","chopping":"241-314","consensus_level":"high","plddt":91.9577,"start":241,"end":314},{"cath_id":"1.20.5","chopping":"59-93","consensus_level":"medium","plddt":83.3146,"start":59,"end":93}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P40424","model_url":"https://alphafold.ebi.ac.uk/files/AF-P40424-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P40424-F1-predicted_aligned_error_v6.png","plddt_mean":69.25},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PBX1","jax_strain_url":"https://www.jax.org/strain/search?query=PBX1"},"sequence":{"accession":"P40424","fasta_url":"https://rest.uniprot.org/uniprotkb/P40424.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P40424/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P40424"}},"corpus_meta":[{"pmid":"10052460","id":"PMC_10052460","title":"Structure of a HoxB1-Pbx1 heterodimer bound to DNA: role of the hexapeptide and a fourth homeodomain helix in complex formation.","date":"1999","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/10052460","citation_count":280,"is_preprint":false},{"pmid":"11566859","id":"PMC_11566859","title":"Requirement for Pbx1 in skeletal patterning and programming chondrocyte proliferation and differentiation.","date":"2001","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11566859","citation_count":249,"is_preprint":false},{"pmid":"11823037","id":"PMC_11823037","title":"Differential expression of Hox, Meis1, and Pbx1 genes in primitive cells throughout murine hematopoietic ontogeny.","date":"2002","source":"Experimental hematology","url":"https://pubmed.ncbi.nlm.nih.gov/11823037","citation_count":225,"is_preprint":false},{"pmid":"8104101","id":"PMC_8104101","title":"Chimeric homeobox gene E2A-PBX1 induces proliferation, apoptosis, and malignant lymphomas in transgenic mice.","date":"1993","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/8104101","citation_count":183,"is_preprint":false},{"pmid":"12923056","id":"PMC_12923056","title":"Structure of HoxA9 and Pbx1 bound to DNA: Hox hexapeptide and DNA recognition anterior to posterior.","date":"2003","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/12923056","citation_count":168,"is_preprint":false},{"pmid":"9405651","id":"PMC_9405651","title":"Meis1 and pKnox1 bind DNA cooperatively with Pbx1 utilizing an interaction surface disrupted in oncoprotein E2a-Pbx1.","date":"1997","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9405651","citation_count":167,"is_preprint":false},{"pmid":"11912494","id":"PMC_11912494","title":"Pbx1 inactivation disrupts pancreas development and in Ipf1-deficient mice promotes diabetes mellitus.","date":"2002","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11912494","citation_count":158,"is_preprint":false},{"pmid":"22125492","id":"PMC_22125492","title":"PBX1 genomic pioneer function drives ERα signaling underlying progression in breast cancer.","date":"2011","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22125492","citation_count":158,"is_preprint":false},{"pmid":"16672333","id":"PMC_16672333","title":"Pbx1/Pbx2 requirement for distal limb patterning is mediated by the hierarchical control of Hox gene spatial distribution and Shh expression.","date":"2006","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/16672333","citation_count":154,"is_preprint":false},{"pmid":"7565734","id":"PMC_7565734","title":"The pentapeptide motif of Hox proteins is required for cooperative DNA binding with Pbx1, physically contacts Pbx1, and enhances DNA binding by Pbx1.","date":"1995","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/7565734","citation_count":141,"is_preprint":false},{"pmid":"7791786","id":"PMC_7791786","title":"Both Pbx1 and E2A-Pbx1 bind the DNA motif ATCAATCAA cooperatively with the products of multiple murine Hox genes, some of which are themselves oncogenes.","date":"1995","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/7791786","citation_count":136,"is_preprint":false},{"pmid":"14595835","id":"PMC_14595835","title":"Pbx1 is essential for adrenal development and urogenital differentiation.","date":"2003","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/14595835","citation_count":133,"is_preprint":false},{"pmid":"19522013","id":"PMC_19522013","title":"KLF4 and PBX1 directly regulate NANOG expression in human embryonic stem cells.","date":"2009","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/19522013","citation_count":110,"is_preprint":false},{"pmid":"15944191","id":"PMC_15944191","title":"A Pbx1-dependent genetic and transcriptional network regulates spleen ontogeny.","date":"2005","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/15944191","citation_count":107,"is_preprint":false},{"pmid":"27354364","id":"PMC_27354364","title":"A PBX1 transcriptional network controls dopaminergic neuron development and is impaired in Parkinson's disease.","date":"2016","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/27354364","citation_count":100,"is_preprint":false},{"pmid":"8657138","id":"PMC_8657138","title":"Structural determinants within Pbx1 that mediate cooperative DNA binding with pentapeptide-containing Hox proteins: proposal for a model of a Pbx1-Hox-DNA complex.","date":"1996","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8657138","citation_count":96,"is_preprint":false},{"pmid":"12591246","id":"PMC_12591246","title":"Pbx1 regulates nephrogenesis and ureteric branching in the developing kidney.","date":"2003","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/12591246","citation_count":93,"is_preprint":false},{"pmid":"9032278","id":"PMC_9032278","title":"E2a-Pbx1 induces aberrant expression of tissue-specific and developmentally regulated genes when expressed in NIH 3T3 fibroblasts.","date":"1997","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9032278","citation_count":88,"is_preprint":false},{"pmid":"7577680","id":"PMC_7577680","title":"Hox gene products modulate the DNA binding activity of Pbx1 and Pbx2.","date":"1995","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/7577680","citation_count":77,"is_preprint":false},{"pmid":"16166636","id":"PMC_16166636","title":"Hoxb1 enhancer and control of rhombomere 4 expression: complex interplay between PREP1-PBX1-HOXB1 binding sites.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16166636","citation_count":74,"is_preprint":false},{"pmid":"32238574","id":"PMC_32238574","title":"PBX1 expression in uterine natural killer cells drives fetal growth.","date":"2020","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32238574","citation_count":72,"is_preprint":false},{"pmid":"18974129","id":"PMC_18974129","title":"Identification of Pbx1, a potential oncogene, as a Notch3 target gene in ovarian cancer.","date":"2008","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/18974129","citation_count":64,"is_preprint":false},{"pmid":"27590741","id":"PMC_27590741","title":"Ovarian Cancer Chemoresistance Relies on the Stem Cell Reprogramming Factor PBX1.","date":"2016","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/27590741","citation_count":62,"is_preprint":false},{"pmid":"20439491","id":"PMC_20439491","title":"Pbx1 represses osteoblastogenesis by blocking Hoxa10-mediated recruitment of chromatin remodeling factors.","date":"2010","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20439491","citation_count":61,"is_preprint":false},{"pmid":"26301816","id":"PMC_26301816","title":"Comparative genomics reveals multistep pathogenesis of E2A-PBX1 acute lymphoblastic leukemia.","date":"2015","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/26301816","citation_count":57,"is_preprint":false},{"pmid":"35261206","id":"PMC_35261206","title":"m6 A-mediated regulation of PBX1-GCH1 axis promotes gastric cancer proliferation and metastasis by elevating tetrahydrobiopterin levels.","date":"2022","source":"Cancer communications (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/35261206","citation_count":56,"is_preprint":false},{"pmid":"10825160","id":"PMC_10825160","title":"Functional cloning and characterization of a novel nonhomeodomain protein that inhibits the binding of PBX1-HOX complexes to DNA.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10825160","citation_count":56,"is_preprint":false},{"pmid":"17244677","id":"PMC_17244677","title":"B-cell development fails in the absence of the Pbx1 proto-oncogene.","date":"2007","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/17244677","citation_count":55,"is_preprint":false},{"pmid":"19767769","id":"PMC_19767769","title":"Pbx1 is a downstream target of Evi-1 in hematopoietic stem/progenitors and leukemic cells.","date":"2009","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/19767769","citation_count":55,"is_preprint":false},{"pmid":"28322463","id":"PMC_28322463","title":"A tale of TALE, PREP1, PBX1, and MEIS1: Interconnections and competition in cancer.","date":"2017","source":"BioEssays : news and reviews in molecular, cellular and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/28322463","citation_count":53,"is_preprint":false},{"pmid":"23044487","id":"PMC_23044487","title":"GCN5 acetylates and regulates the stability of the oncoprotein E2A-PBX1 in acute lymphoblastic leukemia.","date":"2012","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/23044487","citation_count":53,"is_preprint":false},{"pmid":"16421192","id":"PMC_16421192","title":"Direct regulation of egl-1 and of programmed cell death by the Hox protein MAB-5 and by CEH-20, a C. elegans homolog of Pbx1.","date":"2006","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/16421192","citation_count":53,"is_preprint":false},{"pmid":"9010234","id":"PMC_9010234","title":"Heterodimerization of Hox proteins with Pbx1 and oncoprotein E2a-Pbx1 generates unique DNA-binding specifities at nucleotides predicted to contact the N-terminal arm of the Hox homeodomain--demonstration of Hox-dependent targeting of E2a-Pbx1 in vivo.","date":"1997","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/9010234","citation_count":49,"is_preprint":false},{"pmid":"24578510","id":"PMC_24578510","title":"Prep1 and Meis1 competition for Pbx1 binding regulates protein stability and tumorigenesis.","date":"2014","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/24578510","citation_count":48,"is_preprint":false},{"pmid":"27461063","id":"PMC_27461063","title":"Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia.","date":"2016","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/27461063","citation_count":47,"is_preprint":false},{"pmid":"16637071","id":"PMC_16637071","title":"PLZF regulates Pbx1 transcription and Pbx1-HoxC8 complex leads to androgen-independent prostate cancer proliferation.","date":"2006","source":"The Prostate","url":"https://pubmed.ncbi.nlm.nih.gov/16637071","citation_count":46,"is_preprint":false},{"pmid":"26215677","id":"PMC_26215677","title":"The pioneer factor PBX1 is a novel driver of metastatic progression in ERα-positive breast cancer.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26215677","citation_count":46,"is_preprint":false},{"pmid":"30718275","id":"PMC_30718275","title":"Inhibition of the deubiquitinase USP9x induces pre-B cell homeobox 1 (PBX1) degradation and thereby stimulates prostate cancer cell apoptosis.","date":"2019","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30718275","citation_count":46,"is_preprint":false},{"pmid":"28263391","id":"PMC_28263391","title":"Overexpression of lipid metabolism genes and PBX1 in the contralateral breasts of women with estrogen receptor-negative breast cancer.","date":"2017","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/28263391","citation_count":46,"is_preprint":false},{"pmid":"10026229","id":"PMC_10026229","title":"Fibroblast growth factor-8 expression is regulated by intronic engrailed and Pbx1-binding sites.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10026229","citation_count":45,"is_preprint":false},{"pmid":"30631148","id":"PMC_30631148","title":"Wnt5a and ROR1 activate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targeting.","date":"2019","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/30631148","citation_count":44,"is_preprint":false},{"pmid":"31885790","id":"PMC_31885790","title":"NANOG Attenuates Hair Follicle-Derived Mesenchymal Stem Cell Senescence by Upregulating PBX1 and Activating AKT Signaling.","date":"2019","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/31885790","citation_count":42,"is_preprint":false},{"pmid":"21746878","id":"PMC_21746878","title":"Cooperative transcriptional activation by Klf4, Meis2, and Pbx1.","date":"2011","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/21746878","citation_count":42,"is_preprint":false},{"pmid":"28261581","id":"PMC_28261581","title":"PBX1 as Pioneer Factor: A Case Still Open.","date":"2017","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/28261581","citation_count":41,"is_preprint":false},{"pmid":"27226325","id":"PMC_27226325","title":"Pbx1 is required for adult subventricular zone neurogenesis.","date":"2016","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/27226325","citation_count":41,"is_preprint":false},{"pmid":"22567123","id":"PMC_22567123","title":"Identification of PBX1 target genes in cancer cells by global mapping of PBX1 binding sites.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22567123","citation_count":41,"is_preprint":false},{"pmid":"37889101","id":"PMC_37889101","title":"Exosomal lncRNA NEAT1 Inhibits NK-Cell Activity to Promote Multiple Myeloma Cell Immune Escape via an EZH2/PBX1 Axis.","date":"2024","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/37889101","citation_count":40,"is_preprint":false},{"pmid":"10637514","id":"PMC_10637514","title":"An inhibitory switch derepressed by pbx, hox, and Meis/Prep1 partners regulates DNA-binding by pbx1 and E2a-pbx1 and is dispensable for myeloid immortalization by E2a-pbx1.","date":"1999","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/10637514","citation_count":39,"is_preprint":false},{"pmid":"9191052","id":"PMC_9191052","title":"The highest affinity DNA element bound by Pbx complexes in t(1;19) leukemic cells fails to mediate cooperative DNA-binding or cooperative transactivation by E2a-Pbx1 and class I Hox proteins - evidence for selective targetting of E2a-Pbx1 to a subset of Pbx-recognition elements.","date":"1997","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/9191052","citation_count":38,"is_preprint":false},{"pmid":"18691704","id":"PMC_18691704","title":"Pbx1/Pbx2 govern axial skeletal development by controlling Polycomb and Hox in mesoderm and Pax1/Pax9 in sclerotome.","date":"2008","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/18691704","citation_count":38,"is_preprint":false},{"pmid":"16328158","id":"PMC_16328158","title":"Pbx1 is required for Hox D3-mediated angiogenesis.","date":"2005","source":"Angiogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/16328158","citation_count":36,"is_preprint":false},{"pmid":"8622127","id":"PMC_8622127","title":"The divergent homeobox gene PBX1 is expressed in the postnatal subventricular zone and interneurons of the olfactory bulb.","date":"1996","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/8622127","citation_count":36,"is_preprint":false},{"pmid":"32276273","id":"PMC_32276273","title":"E2A-PBX1 functions as a coactivator for RUNX1 in acute lymphoblastic leukemia.","date":"2020","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/32276273","citation_count":35,"is_preprint":false},{"pmid":"7547467","id":"PMC_7547467","title":"Localization of Pbx1 transcripts in developing rat embryos.","date":"1995","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/7547467","citation_count":35,"is_preprint":false},{"pmid":"22972988","id":"PMC_22972988","title":"Structural basis of CBP/p300 recruitment in leukemia induction by E2A-PBX1.","date":"2012","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/22972988","citation_count":34,"is_preprint":false},{"pmid":"35015835","id":"PMC_35015835","title":"Systems medicine dissection of chr1q-amp reveals a novel PBX1-FOXM1 axis for targeted therapy in multiple myeloma.","date":"2022","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/35015835","citation_count":32,"is_preprint":false},{"pmid":"27758892","id":"PMC_27758892","title":"E2A-PBX1 Remodels Oncogenic Signaling Networks in B-cell Precursor Acute Lymphoid Leukemia.","date":"2016","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/27758892","citation_count":31,"is_preprint":false},{"pmid":"32169072","id":"PMC_32169072","title":"A novel c-Kit/phospho-prohibitin axis enhances ovarian cancer stemness and chemoresistance via Notch3-PBX1 and β-catenin-ABCG2 signaling.","date":"2020","source":"Journal of biomedical science","url":"https://pubmed.ncbi.nlm.nih.gov/32169072","citation_count":31,"is_preprint":false},{"pmid":"23660001","id":"PMC_23660001","title":"Pbx1 restrains myeloid maturation while preserving lymphoid potential in hematopoietic progenitors.","date":"2013","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/23660001","citation_count":30,"is_preprint":false},{"pmid":"34529123","id":"PMC_34529123","title":"PBX1: a key character of the hallmarks of cancer.","date":"2021","source":"Journal of molecular medicine (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/34529123","citation_count":29,"is_preprint":false},{"pmid":"29694893","id":"PMC_29694893","title":"SETDB2 Links E2A-PBX1 to Cell-Cycle Dysregulation in Acute Leukemia through CDKN2C Repression.","date":"2018","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/29694893","citation_count":29,"is_preprint":false},{"pmid":"24503810","id":"PMC_24503810","title":"Direct and indirect targets of the E2A-PBX1 leukemia-specific fusion protein.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24503810","citation_count":28,"is_preprint":false},{"pmid":"29678569","id":"PMC_29678569","title":"PBX1 promotes the cell proliferation via JAK2/STAT3 signaling in clear cell renal carcinoma.","date":"2018","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/29678569","citation_count":28,"is_preprint":false},{"pmid":"20108353","id":"PMC_20108353","title":"Pbx1 is essential for growth of zebrafish swim bladder.","date":"2010","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/20108353","citation_count":28,"is_preprint":false},{"pmid":"19064610","id":"PMC_19064610","title":"Pre-B-cell leukemia homeobox 1 (PBX1) shows functional and possible genetic association with bone mineral density variation.","date":"2008","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19064610","citation_count":28,"is_preprint":false},{"pmid":"27296664","id":"PMC_27296664","title":"The Lupus Susceptibility Gene Pbx1 Regulates the Balance between Follicular Helper T Cell and Regulatory T Cell Differentiation.","date":"2016","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/27296664","citation_count":28,"is_preprint":false},{"pmid":"10448033","id":"PMC_10448033","title":"NMR studies of the pbx1 TALE homeodomain protein free in solution and bound to DNA: proposal for a mechanism of HoxB1-Pbx1-DNA complex assembly.","date":"1999","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10448033","citation_count":27,"is_preprint":false},{"pmid":"16769578","id":"PMC_16769578","title":"The effects of siRNA-mediated inhibition of E2A-PBX1 on EB-1 and Wnt16b expression in the 697 pre-B leukemia cell line.","date":"2006","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/16769578","citation_count":27,"is_preprint":false},{"pmid":"21922607","id":"PMC_21922607","title":"PBX1: a novel stage-specific regulator of adipocyte development.","date":"2011","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/21922607","citation_count":26,"is_preprint":false},{"pmid":"33542097","id":"PMC_33542097","title":"Mediator subunit MED1 is required for E2A-PBX1-mediated oncogenic transcription and leukemic cell growth.","date":"2021","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/33542097","citation_count":25,"is_preprint":false},{"pmid":"34869323","id":"PMC_34869323","title":"PBX1 Attenuates Hair Follicle-Derived Mesenchymal Stem Cell Senescence and Apoptosis by Alleviating Reactive Oxygen Species-Mediated DNA Damage Instead of Enhancing DNA Damage Repair.","date":"2021","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/34869323","citation_count":25,"is_preprint":false},{"pmid":"10490826","id":"PMC_10490826","title":"EB-1, a tyrosine kinase signal transduction gene, is transcriptionally activated in the t(1;19) subset of pre-B ALL, which express oncoprotein E2a-Pbx1.","date":"1999","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/10490826","citation_count":25,"is_preprint":false},{"pmid":"29312798","id":"PMC_29312798","title":"uc.38 induces breast cancer cell apoptosis via PBX1.","date":"2017","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/29312798","citation_count":24,"is_preprint":false},{"pmid":"8552663","id":"PMC_8552663","title":"Selective repression of transcriptional activators by Pbx1 does not require the homeodomain.","date":"1996","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8552663","citation_count":24,"is_preprint":false},{"pmid":"12487626","id":"PMC_12487626","title":"Cross-talk between glucocorticoid and retinoic acid signals involving glucocorticoid receptor interaction with the homoeodomain protein Pbx1.","date":"2003","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/12487626","citation_count":24,"is_preprint":false},{"pmid":"26075712","id":"PMC_26075712","title":"Associations of Polymorphisms in WNT9B and PBX1 with Mayer-Rokitansky-Küster-Hauser Syndrome in Chinese Han.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26075712","citation_count":23,"is_preprint":false},{"pmid":"11237058","id":"PMC_11237058","title":"The leukemogenic transcription factor E2a-Pbx1 induces expression of the putative N-myc and p53 target gene NDRG1 in Ba/F3 cells.","date":"2001","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/11237058","citation_count":22,"is_preprint":false},{"pmid":"37324936","id":"PMC_37324936","title":"TRIM26 promotes non-small cell lung cancer survival by inducing PBX1 degradation.","date":"2023","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37324936","citation_count":21,"is_preprint":false},{"pmid":"32190943","id":"PMC_32190943","title":"PBX1 promotes development of natural killer cells by binding directly to the Nfil3 promoter.","date":"2020","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/32190943","citation_count":21,"is_preprint":false},{"pmid":"34406703","id":"PMC_34406703","title":"The clinical outcomes and genomic landscapes of acute lymphoblastic leukemia patients with E2A-PBX1: A 10-year retrospective study.","date":"2021","source":"American journal of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/34406703","citation_count":21,"is_preprint":false},{"pmid":"36361531","id":"PMC_36361531","title":"Targeting SPHK1/PBX1 Axis Induced Cell Cycle Arrest in Non-Small Cell Lung Cancer.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36361531","citation_count":20,"is_preprint":false},{"pmid":"33539429","id":"PMC_33539429","title":"Establishment of the TALE-code reveals aberrantly activated homeobox gene PBX1 in Hodgkin lymphoma.","date":"2021","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/33539429","citation_count":20,"is_preprint":false},{"pmid":"34816098","id":"PMC_34816098","title":"Development of small molecule inhibitors targeting PBX1 transcription signaling as a novel cancer therapeutic strategy.","date":"2021","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/34816098","citation_count":20,"is_preprint":false},{"pmid":"35962175","id":"PMC_35962175","title":"PBX1-SIRT1 Positive Feedback Loop Attenuates ROS-Mediated HF-MSC Senescence and Apoptosis.","date":"2022","source":"Stem cell reviews and reports","url":"https://pubmed.ncbi.nlm.nih.gov/35962175","citation_count":18,"is_preprint":false},{"pmid":"38341110","id":"PMC_38341110","title":"PBX1 as a novel master regulator in cancer: Its regulation, molecular biology, and therapeutic applications.","date":"2024","source":"Biochimica et biophysica acta. Reviews on cancer","url":"https://pubmed.ncbi.nlm.nih.gov/38341110","citation_count":18,"is_preprint":false},{"pmid":"18679416","id":"PMC_18679416","title":"Evidence for Hox and E2A-PBX1 collaboration in mouse T-cell leukemia.","date":"2008","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/18679416","citation_count":18,"is_preprint":false},{"pmid":"9408756","id":"PMC_9408756","title":"Hyperdiploidy and E2A-PBX1 fusion in an adult with t(1;19)+ acute lymphoblastic leukemia: case report and review of the literature.","date":"1997","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/9408756","citation_count":18,"is_preprint":false},{"pmid":"17353115","id":"PMC_17353115","title":"Identification of a new type of PBX1 partner that contains zinc finger motifs and inhibits the binding of HOXA9-PBX1 to DNA.","date":"2007","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/17353115","citation_count":18,"is_preprint":false},{"pmid":"36862399","id":"PMC_36862399","title":"Involvement of Transcriptional Factor Pbx1 in Peripheral B Cell Homeostasis to Constrain Lupus Autoimmunity.","date":"2023","source":"Arthritis & rheumatology (Hoboken, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/36862399","citation_count":17,"is_preprint":false},{"pmid":"34976139","id":"PMC_34976139","title":"MicroRNA-141-3p inhibits the progression of oral squamous cell carcinoma via targeting PBX1 through the JAK2/STAT3 pathway.","date":"2021","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34976139","citation_count":17,"is_preprint":false},{"pmid":"32141698","id":"PMC_32141698","title":"Paternal mosaicism for a novel PBX1 mutation associated with recurrent perinatal death: Phenotypic expansion of the PBX1-related syndrome.","date":"2020","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/32141698","citation_count":17,"is_preprint":false},{"pmid":"35451537","id":"PMC_35451537","title":"The TALE never ends: A comprehensive overview of the role of PBX1, a TALE transcription factor, in human developmental defects.","date":"2022","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/35451537","citation_count":16,"is_preprint":false},{"pmid":"32170580","id":"PMC_32170580","title":"PBX1 Increases the Radiosensitivity of Oesophageal Squamous Cancer by Targeting of STAT3.","date":"2020","source":"Pathology oncology research : POR","url":"https://pubmed.ncbi.nlm.nih.gov/32170580","citation_count":15,"is_preprint":false},{"pmid":"27431573","id":"PMC_27431573","title":"Regulation of the miRNA expression by TEL/AML1, BCR/ABL, MLL/AF4 and TCF3/PBX1 oncoproteins in acute lymphoblastic leukemia (Review).","date":"2016","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/27431573","citation_count":15,"is_preprint":false},{"pmid":"31058389","id":"PMC_31058389","title":"The TALE homeodomain of PBX1 is involved in human primary testis-determination.","date":"2019","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/31058389","citation_count":15,"is_preprint":false},{"pmid":"28257976","id":"PMC_28257976","title":"The PBX1 lupus susceptibility gene regulates CD44 expression.","date":"2017","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/28257976","citation_count":14,"is_preprint":false},{"pmid":"34678207","id":"PMC_34678207","title":"PBX1-directed stem cell transcriptional program drives tumor progression in myeloproliferative neoplasm.","date":"2021","source":"Stem cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/34678207","citation_count":14,"is_preprint":false},{"pmid":"23688269","id":"PMC_23688269","title":"Detection of E2A-PBX1 fusion transcripts in human non-small-cell lung cancer.","date":"2013","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/23688269","citation_count":14,"is_preprint":false},{"pmid":"37414772","id":"PMC_37414772","title":"A spatio-temporally constrained gene regulatory network directed by PBX1/2 acquires limb patterning specificity via HAND2.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/37414772","citation_count":14,"is_preprint":false},{"pmid":"19797217","id":"PMC_19797217","title":"Essential role for Pbx1 in corneal morphogenesis.","date":"2009","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/19797217","citation_count":13,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51457,"output_tokens":12181,"usd":0.168543,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":23543,"output_tokens":5238,"usd":0.124332,"stage2_stop_reason":"end_turn"},"total_usd":0.292875,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"Crystal structure (2.35 Å) of a ternary HoxB1-Pbx1-DNA complex revealed that the HoxB1 hexapeptide binds in a hydrophobic pocket in the Pbx1 homeodomain formed by a three-amino-acid insertion; Pbx1 contains an additional fourth alpha-helix C-terminal to the canonical homeodomain that contributes to hexapeptide binding and to stable Pbx1-DNA interaction.\",\n      \"method\": \"X-ray crystallography (2.35 Å resolution)\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — atomic-resolution crystal structure with functional validation, foundational mechanistic paper replicated by subsequent structural studies\",\n      \"pmids\": [\"10052460\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"NMR studies showed that the fourth (C-terminal) alpha-helix of Pbx1 is unfolded in solution and folds only upon DNA binding; no conformational change was detected upon mixing Pbx1 with HoxB1 in the absence of DNA, suggesting DNA binding precedes or is required for stable Hox-Pbx1 complex assembly.\",\n      \"method\": \"Multidimensional NMR spectroscopy (1H, 15N, 13C)\",\n      \"journal\": \"Journal of Molecular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — NMR solution structure with functional mechanistic implication, consistent with and complementary to the crystal structure in PMID 10052460\",\n      \"pmids\": [\"10448033\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Crystal structure (1.9 Å) of a HoxA9-Pbx1-DNA ternary complex revealed that the posterior Hox hexapeptide adopts an altered conformation compared to anterior Hox complexes, and that residues in the N-terminal arm of the Hox homeodomain determine DNA sequence specificity via indirect contacts, providing a structural basis for anterior-posterior Hox binding specificity modulated by Pbx1.\",\n      \"method\": \"X-ray crystallography (1.9 Å), DNA-binding assays with wild-type and mutant proteins\",\n      \"journal\": \"Genes & Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — atomic-resolution structure plus mutagenesis and binding assays in a single rigorous study\",\n      \"pmids\": [\"12923056\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"The conserved pentapeptide motif (F/Y-P-W-M-R/K) located N-terminal to the Hox homeodomain is essential for cooperative DNA binding with Pbx1; point mutations at tryptophan and methionine abolished cooperativity; a wild-type pentapeptide peptide blocked cooperative binding and also stimulated Pbx1 DNA binding alone, establishing direct physical contact between the pentapeptide and Pbx1.\",\n      \"method\": \"In vitro DNA binding assays, point mutational analysis, competitive peptide inhibition\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with mutagenesis and peptide competition, replicated across multiple Hox proteins\",\n      \"pmids\": [\"7565734\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Pbx1 (and E2A-Pbx1) binds DNA cooperatively with multiple Hox proteins (HoxA5, HoxB7, HoxB8, HoxC8, HoxD4) on the ATCAATCAA motif; cooperative binding required the homeodomain-dependent DNA-binding activity of both partners; in cotransfection assays HoxB8 suppressed E2A-Pbx1 transactivation.\",\n      \"method\": \"Electrophoretic mobility shift assay (EMSA), cotransfection/reporter assays\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro binding reconstitution with multiple Hox partners plus functional reporter assays, replicated across labs\",\n      \"pmids\": [\"7791786\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"The Pbx1 homeodomain is sufficient for cooperative DNA binding with pentapeptide-containing Hox proteins; a 25-residue predicted alpha-helix preceding the homeodomain inhibits Pbx1 DNA binding and Hox heterodimerization, and a sequence immediately C-terminal to the homeodomain (highly conserved, predicted alpha-helix) enhances monomeric DNA binding and cooperativity; heterodimerization places Pbx1 on the 5' TTGAT core and Hox on the adjacent 3' TGAT core.\",\n      \"method\": \"In vitro DNA binding assays with deletion and chimeric mutants\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — systematic in vitro mutagenesis and domain-mapping with reconstitution, single lab but multiple constructs\",\n      \"pmids\": [\"8657138\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Meis1 and pKnox1 dimerize with Pbx1 on a TGATTGAC motif; the Meis1/pKnox1-interaction domain in Pbx1 resides predominantly in a conserved N-terminal Pbx domain that is deleted in E2A-Pbx1, explaining why Meis1/pKnox1 fail to bind E2A-Pbx1; HPIP (a novel protein) also interacts with Pbx1 through the homeodomain and flanking sequences and inhibits PBX-HOX heterodimer DNA binding.\",\n      \"method\": \"EMSA, co-immunoprecipitation, yeast two-hybrid\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal binding assays, domain-deletion mapping, and functional EMSA inhibition; replicated in part by PMID 10825160\",\n      \"pmids\": [\"9405651\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"A novel protein HPIP (hematopoietic PBX-interacting protein) was identified by yeast two-hybrid as a Pbx1 interactor; HPIP is mainly cytosolic; it interacts with Pbx1 via the homeodomain and flanking sequences; HPIP inhibits PBX-HOX heterodimer DNA binding in EMSA and strongly inhibits E2A-PBX1 transactivation.\",\n      \"method\": \"Yeast two-hybrid, EMSA, transactivation reporter assays, subcellular fractionation\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — yeast two-hybrid plus functional EMSA and reporter assay, single lab\",\n      \"pmids\": [\"10825160\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"An inhibitory 25-residue alpha-helix immediately N-terminal to the Pbx1 homeodomain binds the homeodomain and prevents DNA binding and Hox heterodimerization; an additional 39-residue region N-terminal to this helix mediates Pbx homodimerization and heterodimerization on DNA; Hox and Meis1/Prep1 partners relieve the inhibitory switch; the inhibitory switch is dispensable for myeloid immortalization by E2A-Pbx1.\",\n      \"method\": \"In vitro DNA binding assays, deletion mutagenesis, myeloid immortalization assays\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with systematic mutagenesis, single lab\",\n      \"pmids\": [\"10637514\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Pbx1 heterodimers with different Hox proteins bind distinct DNA motifs; unique sequences in the N-terminal arm of the Hox homeodomain mediate this differential specificity; in vivo, Hox proteins directed E2A-Pbx1-mediated transactivation to cognate Hox-Pbx motifs, demonstrating Hox-dependent targeting of Pbx1 complexes to distinct genomic sites.\",\n      \"method\": \"EMSA with recombinant proteins, cotransfection/reporter assays, structural modeling\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro binding assays plus in vivo reporter assays with mutants, single lab\",\n      \"pmids\": [\"9010234\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"Expression of the E2A-PBX1 chimeric homeodomain protein under control of the immunoglobulin heavy chain enhancer in transgenic mice induced T-cell lymphomas and paradoxically increased both cell cycling and apoptosis in pretumorous lymphoid cells, establishing that the fusion oncogene simultaneously drives proliferation and programmed cell death in lymphoid cells in vivo.\",\n      \"method\": \"Transgenic mouse model, flow cytometry, histopathology\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean transgenic in vivo loss-of-function model with defined cellular phenotypes, replicated by later conditional mouse models\",\n      \"pmids\": [\"8104101\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Pbx1-deficient mice die at E15/16 with widespread skeletal patterning defects restricted to Hox-dimerization-motif-bearing protein domains; in affected limbs and ribs, chondrocyte proliferation was markedly reduced with premature hypertrophy and precocious Col1a1 expression, establishing Pbx1 as a regulator of chondrocyte proliferation/differentiation timing without altering Hox gene expression.\",\n      \"method\": \"Pbx1 knockout mouse, histology, in situ hybridization, molecular marker analysis\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean constitutive knockout with detailed molecular and cellular phenotyping, widely replicated\",\n      \"pmids\": [\"11566859\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Pbx1-deficient embryos display pancreatic hypoplasia with severe defects in exocrine and endocrine cell differentiation; expression of Isl1 and Atoh5 was severely reduced; compound Pbx1+/−;Ipf1+/− mice develop overt diabetes, establishing in vivo genetic interaction between Pbx1 and Ipf1 (Pdx1) required for postnatal pancreatic function.\",\n      \"method\": \"Pbx1 knockout mouse, compound heterozygous mouse genetics (epistasis), molecular marker analysis, glucose tolerance testing\",\n      \"journal\": \"Nature Genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — constitutive and trans-heterozygous genetic epistasis with detailed molecular phenotyping\",\n      \"pmids\": [\"11912494\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Pbx1-deficient mice completely lack adrenal glands; expression of steroidogenic factor-1 (SF-1) was reduced to minimal levels in Pbx1 mutant genital ridges, placing Pbx1 upstream of SF-1 in the adrenocortical development pathway; loss of Pbx1 also impaired Müllerian duct formation and mesonephric differentiation.\",\n      \"method\": \"Pbx1 knockout mouse, molecular marker analysis (SF-1 expression), histology\",\n      \"journal\": \"Genesis\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean constitutive knockout with defined upstream pathway placement via molecular marker\",\n      \"pmids\": [\"14595835\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"In Pbx1-deficient kidneys, ureteric branching and elongation were reduced and nephron number was decreased; heterologous recombination explant cultures demonstrated that renal defects arose exclusively from mesenchymal (not ureteric) dysfunction, establishing Pbx1 as a regulator of mesenchymal-epithelial signaling during renal morphogenesis.\",\n      \"method\": \"Pbx1 knockout mouse, kidney explant heterologous recombination assays, molecular marker analysis\",\n      \"journal\": \"Developmental Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean knockout with tissue-specific rescue/chimera assay localizing defect to mesenchyme\",\n      \"pmids\": [\"12591246\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"ChIP assays showed that Pbx1 binds the Hox11 promoter in spleen mesenchymal cells; Hox11 and Nkx2.5 expression are absent in Pbx1-null splenic anlage; Pbx1 and Hox11 genetically interact in spleen formation (double mutants have exacerbated phenotypes), establishing Pbx1 as a hierarchical upstream regulator in a Pbx1-Hox11 transcriptional pathway for spleen ontogeny.\",\n      \"method\": \"Pbx1/Hox11 double mutant mouse genetics, ChIP, in situ hybridization\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis combined with direct ChIP occupancy of target promoter\",\n      \"pmids\": [\"15944191\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Pbx1/Pbx2 compound loss-of-function mice exhibit severe distal limb defects and Pbx1−/−;Pbx2−/− embryos lack limbs entirely; these defects are mediated by hierarchical control of Hox gene spatial distribution and Shh expression in the posterior limb/ZPA, demonstrating that Pbx1/Pbx2 act upstream of Hox genes and Shh to control limb axis patterning.\",\n      \"method\": \"Pbx1/Pbx2 double knockout mouse, in situ hybridization, molecular marker analysis\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — compound knockout with molecular epistasis placing Pbx1/2 upstream of Hox and Shh\",\n      \"pmids\": [\"16672333\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Pbx1/Pbx2 compound loss-of-function establishes that axial skeletal patterning requires Pbx1/2 through genetic control of Polycomb and Hox expression in mesoderm and Pax1/Pax9 expression in sclerotome, placing Pbx1/2 in a hierarchical position above these axial patterning regulators.\",\n      \"method\": \"Pbx1/Pbx2 double knockout mouse, molecular marker analysis (Polycomb, Hox, Pax1/Pax9)\",\n      \"journal\": \"Developmental Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — compound knockout with molecular epistasis, single lab\",\n      \"pmids\": [\"18691704\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Using Rag1-deficient blastocyst complementation, Pbx1-null ES cells failed to generate common lymphoid progenitors (CLPs), resulting in complete absence of B and NK cells and partial impairment of T-cell development; restoration of Pbx1 expression rescued B-cell development from CLPs; conditional inactivation in pro-B (CD19+) cells showed Pbx1 is not required after CLP commitment, placing its essential function between HSC and CLP stages.\",\n      \"method\": \"Blastocyst complementation (Rag1-deficient), conditional gene rescue, adoptive transfer, flow cytometry\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple complementary in vivo approaches (complementation + rescue + conditional KO) placing Pbx1 function at specific developmental stage\",\n      \"pmids\": [\"17244677\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Pbx1 is a direct transcriptional target of Evi-1; Evi-1 overexpression upregulates Pbx1 transcription via the Pbx1 promoter; RNAi knockdown of Pbx1 inhibits Evi-1-induced bone marrow transformation but not transformation by E2A/HLF or AML1/ETO, establishing Pbx1 as specifically required downstream of Evi-1 in leukemogenesis.\",\n      \"method\": \"Promoter reporter assays, RNAi knockdown, bone marrow transformation assays, genetic epistasis\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — promoter analysis plus functional epistasis via RNAi, single lab\",\n      \"pmids\": [\"19767769\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"KLF4 and PBX1 are transcriptional activators of NANOG in human ESCs; PBX1 binds directly to a novel upstream enhancer and the proximal NANOG promoter (confirmed by ChIP and EMSA); knockdown or mutation of PBX1 binding sites reduces NANOG promoter activity; PBX1 cooperates synergistically with OCT4 and SOX2 to transactivate NANOG.\",\n      \"method\": \"ChIP, EMSA, luciferase reporter assay, RNAi knockdown, overexpression in hESCs\",\n      \"journal\": \"Stem Cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct binding confirmed by ChIP and EMSA plus functional reporter assays, single lab\",\n      \"pmids\": [\"19522013\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Pbx1 negatively regulates Hoxa10-mediated osteoblast gene transcription; ChIP showed Pbx1 is associated with histone deacetylases (HDACs) at osteoblast-related gene promoters; loss of Pbx1 from promoters during differentiation correlates with increased histone acetylation, CBP/p300 recruitment, and decreased H3K9 methylation; Pbx1 acts through a Pbx-binding site that attenuates Hoxa10-mediated activation of osteocalcin and Bsp promoters.\",\n      \"method\": \"ChIP, shRNA knockdown, reporter assays with wild-type and mutant promoters, overexpression in mesenchymal cells\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus functional reporter assays and knockdown, single lab\",\n      \"pmids\": [\"20439491\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"PBX1 acts as a pioneer factor in breast cancer cells: ChIP-seq and FAIRE-seq showed PBX1 is loaded at specific genomic locations with open chromatin, promotes chromatin accessibility, reads specific epigenetic signatures, and guides ERα recruitment to a specific subset of genomic sites; PBX1 depletion abolishes estrogen-stimulated proliferation and controls >70% of the estrogen transcriptional response.\",\n      \"method\": \"ChIP-seq, FAIRE-seq, shRNA knockdown, expression profiling\",\n      \"journal\": \"PLoS Genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genome-wide ChIP-seq plus chromatin accessibility (FAIRE-seq) plus functional knockdown, multiple orthogonal methods\",\n      \"pmids\": [\"22125492\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"GCN5 (acetyltransferase subunit of the STAGA complex) directly interacts with the E2A portion of E2A-PBX1, acetylates E2A-PBX1, and increases its protein stability in cells; the E3 ubiquitin ligase HDM2 promotes E2A-PBX1 degradation; GCN5 inhibitor MB-3 decreases E2A-PBX1 acetylation and protein levels in leukemic cells.\",\n      \"method\": \"Co-immunoprecipitation, in vitro/cell-based acetylation assays, Western blot, pharmacological inhibition\",\n      \"journal\": \"Leukemia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP and biochemical acetylation assays, single lab\",\n      \"pmids\": [\"23044487\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Structural determination of the E2A PCET motif bound to the KIX domain of CBP/p300; residues throughout the helical PCET motif contact KIX; these residues are required for both KIX binding and bone marrow immortalization by E2A-PBX1, establishing the PCET/KIX interaction as mechanistically required for E2A-PBX1 leukemogenic activity.\",\n      \"method\": \"NMR/X-ray structural determination of peptide-KIX complex, mutagenesis, bone marrow immortalization assay\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — structure plus mutagenesis plus functional assay in one study, single lab\",\n      \"pmids\": [\"22972988\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Pbx1 binds Hoxb1 autoregulatory enhancer elements (PH and PM sites); Prep1-Pbx1 forms ternary complexes with Hoxb1 at the R3/PM2 combination sufficient to drive hindbrain r4 reporter expression in vivo; a high-affinity PM site (R2/PM3) inhibits ternary complex formation and restricts reporter expression, demonstrating that multiple Prep1-Pbx1 and Pbx1-Hox binding sites cooperate to modulate Hoxb1 autoregulation.\",\n      \"method\": \"In vitro binding assays, transgenic reporter analysis in chick and mouse embryos, mutagenesis of binding sites\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — binding assays plus in vivo transgenic reporter with mutagenesis, single lab\",\n      \"pmids\": [\"16166636\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Pbx1 is a direct transcriptional target of Notch3; the Notch3/CSL protein complex binds directly to the CSL-binding sequence in the Pbx1 promoter; ectopic Pbx1 expression partially reverses the growth-inhibitory effect of gamma-secretase inhibitor; Pbx1 shRNA knockdown reduces cell proliferation and tumorigenicity in ovarian cancer cells.\",\n      \"method\": \"ChIP (Notch3/CSL-Pbx1 promoter), reporter assay, shRNA knockdown, rescue experiment with ectopic expression\",\n      \"journal\": \"Cancer Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct promoter binding by ChIP plus functional rescue experiment, single lab\",\n      \"pmids\": [\"18974129\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Prep1 and Meis1 competitively heterodimerize with Pbx1; Prep1 posttranslationally reduces Meis1 stability by sequestering Pbx1 from Meis1; loss of Prep1 allows Meis1 to remain bound to Pbx1 and remain stable, enabling oncogenic transformation; Pbx1 can therefore function as either oncogene or tumor suppressor depending on which partner (Meis1 vs. Prep1) it dimerizes with.\",\n      \"method\": \"Co-immunoprecipitation, protein stability assays, transformation assays in mouse embryonic fibroblasts, overexpression/knockdown\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP plus protein stability and transformation assays, single lab\",\n      \"pmids\": [\"24578510\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"PBX1 directly represses Onecut2 (to inhibit lateral fates) and directly activates Pitx3 (to promote mDAn development) and Nfe2l1 (to protect from oxidative stress) in midbrain dopaminergic neurons; PBX1 and NFE2L1 levels are severely reduced in dopaminergic neurons of the substantia nigra in Parkinson's disease patients.\",\n      \"method\": \"ChIP, conditional knockout mouse (loss of function), gene expression analysis, human PD tissue analysis\",\n      \"journal\": \"The EMBO Journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus conditional KO with defined gene targets, single lab\",\n      \"pmids\": [\"27354364\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"PBX1 directly binds the STAT3 promoter and positively regulates STAT3 transcription in ovarian cancer; silencing PBX1 in platinum-resistant cells reduces stem-like properties and sensitizes cells to carboplatin; a STAT3/JAK2 inhibitor potently sensitizes platinum-resistant cells to carboplatin in vivo.\",\n      \"method\": \"ChIP, shRNA knockdown, overexpression, in vivo xenograft model\",\n      \"journal\": \"Cancer Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct ChIP binding plus functional knockdown/rescue assays, single lab\",\n      \"pmids\": [\"27590741\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Pbx1-d (dominant-negative isoform lacking DNA-binding and Hox-binding domains) expression in CD4+ T cells expands follicular helper T cells (TFH) and impairs Foxp3+ Treg homeostasis; Pbx1-d-Tg CD4+ T cells upregulate miR-10a, miR-21, and miR-155; Pbx1-d directly regulates CD44 expression through two promoter binding sites, with enhanced MEIS co-factor recruitment relative to normal Pbx1-b.\",\n      \"method\": \"Transgenic mouse model, flow cytometry, ChIP, reporter assay, co-factor recruitment assay\",\n      \"journal\": \"Journal of Immunology / Molecular Immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — transgenic mouse plus ChIP and co-factor assays, single lab across two papers\",\n      \"pmids\": [\"27296664\", \"28257976\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Pbx1 restrains myeloid maturation and maintains lymphoid potential in multipotent progenitors; conditional Pbx1 knockout reduces MPP and CMP pools due to aberrantly rapid myeloid differentiation, associated with premature myeloid gene expression and reduced Meis1 expression (a Pbx1 dimerization partner), placing Pbx1 upstream of Meis1-dependent transcriptional programs in hematopoietic progenitor lineage specification.\",\n      \"method\": \"Conditional Pbx1 knockout mouse, flow cytometry of purified progenitors, transcriptional profiling, proliferation/differentiation assays\",\n      \"journal\": \"Journal of Cell Science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with purified progenitor analysis and transcriptional profiling, single lab\",\n      \"pmids\": [\"23660001\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Pbx1 is required for adult subventricular zone (SVZ) neurogenesis; retroviral Cre-mediated deletion in Pbx2-deficient SVZ stem/progenitor cells significantly reduced neuron production and increased oligodendrocyte generation; loss of Pbx1 in neuroblasts compromised cell survival; ChIP from endogenous tissues detected PBX1 binding to regulatory regions of Dcx and Th weeks before their expression, suggesting a priming/pioneer role.\",\n      \"method\": \"Retroviral Cre delivery in conditional/Pbx2-null mice, neurosphere assays, ChIP from endogenous brain tissue\",\n      \"journal\": \"Development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with cell fate analysis plus direct ChIP occupancy, single lab\",\n      \"pmids\": [\"27226325\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"SETDB2 is directly transcriptionally activated by E2A-PBX1 in pre-BCR+ ALL and suppresses expression of cell-cycle inhibitor CDKN2C through histone H3K9 tri-methylation, establishing an oncogenic pathway subordinate to E2A-PBX1 that silences a tumor suppressor.\",\n      \"method\": \"ChIP, shRNA knockdown, H3K9me3 ChIP, in vitro/in vivo leukemia maintenance assays\",\n      \"journal\": \"Cell Reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct ChIP binding of E2A-PBX1 to SETDB2 plus H3K9me3 ChIP on CDKN2C plus functional KD, single lab\",\n      \"pmids\": [\"29694893\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"USP9x deubiquitinase interacts with PBX1 and stabilizes PBX1 protein by attenuating Lys48-linked polyubiquitination; USP9x inhibitor WP1130 induces PBX1 degradation and promotes prostate cancer cell apoptosis, identifying USP9x as a specific deubiquitinase for PBX1.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assays, pharmacological inhibition (WP1130), siRNA knockdown, apoptosis assays\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP plus biochemical ubiquitination assay plus functional rescue, single lab\",\n      \"pmids\": [\"30718275\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PBX1 promotes NK cell development by directly binding the Nfil3 promoter and upregulating NFIL3/E4BP4 transcription; conditional PBX1 knockout in hematopoietic cells reduces pre-NKP and rNKP progenitors similarly to NFIL3 deficiency; CRISPR knockout of the PBX1-binding site in the Nfil3 promoter in vivo reduces NK precursor and mature NK cells; asparagine N286 in the PBX1 homeodomain is required for Nfil3 promoter binding.\",\n      \"method\": \"Conditional knockout mouse, CRISPR-mediated binding-site deletion in vivo, ChIP, site-directed mutagenesis\",\n      \"journal\": \"FASEB Journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO plus in vivo CRISPR binding-site deletion plus ChIP plus homeodomain mutagenesis, multiple orthogonal approaches\",\n      \"pmids\": [\"32190943\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PBX1 expression in decidual NK (dNK) cells is upregulated through AKT1 pathway activation downstream of MHC-G/ILT2 receptor interaction; PBX1 drives pleiotrophin and osteoglycin transcription in dNK cells to promote fetal development; Pbx1 inactivation in mouse dNK cells impairs fetal development by reducing growth-promoting factors from CD49a+PBX1+ dNK cells.\",\n      \"method\": \"Conditional knockout mouse (dNK-specific), pathway inhibition, ChIP/transcriptional assays, human patient samples\",\n      \"journal\": \"Science Translational Medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with defined target genes and upstream pathway, single lab\",\n      \"pmids\": [\"32238574\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"E2A-PBX1 preferentially binds genomic loci co-occupied by RUNX1 and gene-activating machinery (p300, MED1, H3K27ac); E2A-PBX1 directly interacts with RUNX1 through the PBX1 homeodomain region; E2A-PBX1 chromatin binding at enhancers depends on the RUNX1 interaction but not on PBX1 homeodomain DNA-binding activity; RUNX1 is required for E2A-PBX1 target gene activation and leukemogenesis; E2A-PBX1 also directly activates the RUNX1 locus itself.\",\n      \"method\": \"ChIP-seq, co-immunoprecipitation, CRISPR/mutagenesis, transcriptome analysis, cell transformation assays\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genome-wide ChIP-seq plus reciprocal co-IP plus mutagenesis plus functional leukemogenesis assay, multiple orthogonal methods\",\n      \"pmids\": [\"32276273\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Mediator subunit MED1 directly interacts with the E2A activation domain of E2A-PBX1; MED1 depletion by CRISPR/Cas9 specifically impairs E2A-PBX1-dependent gene activation and leukemic cell growth; DNA-bound RUNX1 recruits E2A-PBX1 to target loci and EBF1 further stabilizes this interaction, establishing a multi-factor complex required for E2A-PBX1 oncogenic transcription.\",\n      \"method\": \"Co-immunoprecipitation, CRISPR/Cas9 knockout, ChIP-seq, transcriptome analysis, in vitro binding assays\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct binding assay plus CRISPR KO plus multi-omics, multiple orthogonal methods in one study\",\n      \"pmids\": [\"33542097\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Glucocorticoid receptor (GR) physically interacts with Pbx1 in vivo (co-immunoprecipitation); the GR DNA-binding domain is required for GC/RA synergy; GC potentiates RA-induced Hoxb-1 expression through the Pbx1/HOXB1-bound autoregulatory element b1-ARE without requiring GR binding to that element, suggesting GR-Pbx1 cross-talk regulates Hox target gene expression.\",\n      \"method\": \"Co-immunoprecipitation, reporter assays, domain-deletion analysis\",\n      \"journal\": \"Biochemical Journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP plus domain-deletion functional assay, single lab\",\n      \"pmids\": [\"12487626\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"A novel zinc-finger protein ZFPIP physically binds PBX1 in vivo and prevents the binding of HOXA9/PBX1 complexes to their consensus DNA site, identifying a new class of PBX1 inhibitory partner that modulates Hox-PBX1 DNA binding.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, EMSA\",\n      \"journal\": \"Mechanisms of Development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — yeast two-hybrid confirmed by co-IP plus functional EMSA inhibition, single lab\",\n      \"pmids\": [\"17353115\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"A de novo missense mutation p.Arg235Gln in the TALE homeodomain nuclear localization signal of PBX1 impairs nuclear localization of the protein and abolishes its physical interaction with CBX2 and EMX2 (proteins required for testis-determination), providing a mechanism for 46,XY gonadal dysgenesis caused by this mutation.\",\n      \"method\": \"Subcellular localization assay, co-immunoprecipitation, patient mutation analysis\",\n      \"journal\": \"Human Mutation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct co-IP showing loss of interaction plus localization assay for patient mutation, single study\",\n      \"pmids\": [\"31058389\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"METTL3-mediated m6A modification stabilizes PBX1 mRNA; PBX1 acts as a transcription factor inducing GCH1 expression (confirmed by ChIP); the METTL3-PBX1-GCH1 axis increases tetrahydrobiopterin (BH4) levels in gastric cancer cells to promote tumor progression.\",\n      \"method\": \"m6A RIP-seq, ChIP, Western blot, xenograft model, ELISA/LC-MS\",\n      \"journal\": \"Cancer Communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP confirmation of direct PBX1-GCH1 promoter binding plus in vivo xenograft, single lab\",\n      \"pmids\": [\"35261206\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"PBX1 is ectopically expressed in chr1q-amplified multiple myeloma via amplification and epigenetic activation of its 3D regulatory domain; PBX1 binds to reprogrammed superenhancers and directly regulates a FOXM1-dependent transcriptional program; pharmacological disruption with T417 (a novel PBX1 small molecule inhibitor docking to the PBX1-DNA interface) is selectively toxic to chr1q-amp myeloma and solid tumor cells.\",\n      \"method\": \"Multi-omics (ChIP-seq, 3D chromatin), pharmacological inhibition (T417/thiostrepton), patient genomic data integration\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-seq showing direct PBX1-superenhancer binding plus functional inhibitor with selective toxicity, single lab\",\n      \"pmids\": [\"35015835\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Pbx1 directly regulates B-cell homeostasis by targeting proliferation and apoptosis pathway genes; B cell-specific Pbx1 knockout in mice causes excessive humoral responses and enhanced germinal center reactions; ChIP and CUT&TAG assays identified direct Pbx1 target genes controlling B-cell survival and proliferation; enforced PBX1 expression in SLE patient B cells attenuates their survival and proliferative capacity.\",\n      \"method\": \"B cell-specific conditional knockout mouse, ChIP, CUT&TAG, RNA-seq, overexpression in human SLE B cells\",\n      \"journal\": \"Arthritis & Rheumatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with CUT&TAG direct binding plus human cell functional validation, single lab\",\n      \"pmids\": [\"36862399\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"PBX1/2 and HAND2 cooperate to direct a limb-specific gene regulatory network (GRN) in posterior hindlimb mesenchymal cells; tissue-specific and temporally controlled mutagenesis combined with genome-wide PBX1 binding profiling across multiple embryonic tissues shows that HAND2 interacts with subsets of PBX1-bound regions to restrict PBX1 activity to limb-specific GRNs, explaining how ubiquitous PBX1 achieves tissue-specific functions.\",\n      \"method\": \"Conditional/temporal knockout mouse, multi-omics (ChIP-seq across tissues, ATAC-seq), co-immunoprecipitation/interaction assays\",\n      \"journal\": \"Nature Communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — tissue-specific KO with genome-wide PBX1 binding profiling across multiple tissues plus interaction assays, multiple orthogonal methods\",\n      \"pmids\": [\"37414772\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"TRIM26 E3 ubiquitin ligase binds PBX1 (identified by affinity purification-MS) and mediates K48-linked polyubiquitination and proteasomal degradation of PBX1 in a RING domain-dependent manner; TRIM26 inhibits PBX1 transcriptional activity and downregulates PBX1 target gene RNF6.\",\n      \"method\": \"Affinity purification-MS, co-immunoprecipitation, ubiquitination assay, domain deletion (RING), reporter assay, xenograft model\",\n      \"journal\": \"International Journal of Biological Sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — AP-MS identification confirmed by co-IP plus biochemical ubiquitination assay with domain deletion, single lab\",\n      \"pmids\": [\"37324936\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"An internal domain of Pbx1 (upstream of the homeodomain, highly conserved among Pbx proteins) selectively represses transcription induced by the Sp1 activation domain but not VP16 or p53, and this repression activity does not require homeodomain-dependent DNA binding, indicating Pbx1 can regulate transcription through DNA-binding-independent mechanisms.\",\n      \"method\": \"Transient transfection reporter assays, domain-deletion analysis\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — functional reporter assays with systematic domain deletions, single lab, no direct binding partner identified\",\n      \"pmids\": [\"8552663\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"PBX1 is required for MPN progression driven by JAK2V617F; in compound JAK2V617F × Pbx1-null mice (JP model), typical MPN features (thrombocythemia, granulocytosis, splenomegaly, cytokine-independent growth) are absent; PBX1 controls part of the molecular pathways deregulated by JAK2V617F, placing PBX1 as a required co-effector downstream or parallel to JAK2V617F signaling in MPN.\",\n      \"method\": \"Conditional double-mutant mouse model (JAK2V617F × Pbx1 knockout), flow cytometry, transcriptome profiling\",\n      \"journal\": \"Stem Cell Reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — compound genetic model with transcriptomic analysis demonstrating pathway co-dependence, single lab\",\n      \"pmids\": [\"34678207\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PBX1 is a TALE-class homeodomain transcription factor that forms heterodimeric and trimeric complexes with HOX proteins (via hexapeptide-homeodomain pocket interaction), MEIS/PREP1 family members (via a conserved N-terminal domain deleted in E2A-PBX1), and a growing repertoire of non-homeodomain partners (HAND2, RUNX1, GR, CBX2, EMX2, ZFPIP, HPIP); its DNA-binding activity is controlled by an autoinhibitory helix derepressed upon partner binding; it functions as a pioneer factor that opens chromatin and guides binding of ERα and other transcription factors to specific genomic loci; it acts hierarchically upstream of HOX genes, Shh, Polycomb, and multiple organ-specific regulators (SF-1, Nkx2.5/Hox11, NFIL3, Pitx3) to coordinate cell proliferation, differentiation, and organ morphogenesis; and its stability is regulated post-translationally by USP9x-mediated deubiquitination and TRIM26-mediated K48-polyubiquitination for proteasomal degradation, while the oncogenic fusion E2A-PBX1 is acetylated and stabilized by GCN5 and recruits CBP/p300 (via PCET/KIX interaction) and MED1/Mediator to drive leukemic transcriptional programs dependent on co-recruitment of RUNX1.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"PBX1 is a TALE-class homeodomain transcription factor that acts as a hierarchical master regulator of cell proliferation, differentiation, and organ morphogenesis by forming cooperative DNA-binding complexes with partner proteins [#16, #11]. Its homeodomain contains a three-residue insertion that creates a hydrophobic pocket binding the conserved hexapeptide/pentapeptide motif of HOX partners, and an additional C-terminal alpha-helix—unfolded in solution and folded only upon DNA binding—that stabilizes the Pbx-DNA interface [#0, #1, #3]. Heterodimerization positions PBX1 on the 5' TTGAT core adjacent to the HOX 3' site, while the identity of the HOX partner dictates target-site specificity and thereby the genomic loci of the complex [#5, #9, #2]. DNA binding is governed by an autoinhibitory N-terminal alpha-helix that occludes the homeodomain and is derepressed upon binding of HOX or MEIS/PREP1 partners, the latter engaging a conserved N-terminal Pbx domain [#8, #6]. PBX1 functions as a pioneer factor that loads at specific loci, opens chromatin, reads epigenetic signatures, and guides recruitment of partner transcription factors such as ERα [#22], and it occupies target regulatory regions prior to gene activation during neurogenesis [#32]. Genetically, PBX1 sits upstream of HOX genes, Shh, Polycomb, and organ-specific regulators (SF-1, Hox11/Nkx2.5, Pitx3, NFIL3) to control skeletal, limb, pancreatic, adrenal, renal, hematopoietic, and neuronal development [#16, #13, #12, #11, #15, #28, #35]; tissue-restricted partners such as HAND2 confine ubiquitous PBX1 activity to lineage-specific gene regulatory networks [#45]. PBX1 protein stability is set by opposing post-translational modifiers: USP9x deubiquitinates and stabilizes PBX1, whereas TRIM26 mediates K48-linked polyubiquitination and proteasomal degradation [#34, #46]. The oncogenic E2A-PBX1 fusion, which lacks the MEIS-interaction domain, drives leukemic transcription through RUNX1-dependent chromatin co-occupancy and recruitment of CBP/p300 (via the PCET/KIX interaction) and MED1/Mediator [#37, #38, #24]. A de novo p.Arg235Gln mutation in the homeodomain nuclear localization signal causes 46,XY gonadal dysgenesis by impairing nuclear localization and CBX2/EMX2 binding [#41].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Established the molecular basis of cooperative HOX-PBX1 DNA binding, answering how two homeodomain proteins achieve combinatorial specificity neither has alone.\",\n      \"evidence\": \"In vitro DNA-binding assays, point mutagenesis, and peptide competition across multiple HOX proteins on the ATCAATCAA motif\",\n      \"pmids\": [\"7565734\", \"7791786\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve the structural geometry of the contact\", \"In vivo target genes not yet defined\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Mapped PBX1 functional domains, showing the homeodomain suffices for cooperativity, that an N-terminal helix autoinhibits DNA binding, and that PBX1 can also repress transcription independent of DNA binding.\",\n      \"evidence\": \"Domain-deletion and chimeric mutagenesis with in vitro binding and reporter assays\",\n      \"pmids\": [\"8657138\", \"8552663\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of DNA-binding-independent repression had no identified partner\", \"Physiological derepression trigger not defined\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Defined the second partner class (MEIS1/PREP1) and the domain mediating it, explaining why the oncogenic E2A-PBX1 fusion cannot bind MEIS and identifying inhibitory partner HPIP.\",\n      \"evidence\": \"EMSA, co-IP, yeast two-hybrid with domain-deletion mapping\",\n      \"pmids\": [\"9405651\", \"9010234\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish the in vivo consequence of MEIS vs HOX partner choice\", \"HPIP regulation of PBX1 not yet functionally validated in vivo\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Provided the atomic and dynamic structural mechanism: a homeodomain insertion forms the hexapeptide pocket and a fourth helix folds only upon DNA binding, ordering complex assembly.\",\n      \"evidence\": \"X-ray crystallography of HoxB1-Pbx1-DNA and multidimensional NMR of Pbx1\",\n      \"pmids\": [\"10052460\", \"10448033\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not address posterior HOX complexes\", \"Autoinhibitory helix geometry resolved only later\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Resolved the autoinhibitory switch as a discrete N-terminal helix occluding the homeodomain, relieved by HOX and MEIS/PREP1 partners, and showed it is dispensable for E2A-PBX1 immortalization.\",\n      \"evidence\": \"In vitro deletion mutagenesis plus myeloid immortalization assays\",\n      \"pmids\": [\"10637514\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab in vitro mapping\", \"How partner binding mechanically displaces the helix not shown\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Extended the structural model to posterior HOX, showing N-terminal arm residues confer differential DNA specificity, providing a structural basis for anterior-posterior HOX selectivity modulated by PBX1.\",\n      \"evidence\": \"1.9 Å crystal structure of HoxA9-Pbx1-DNA with mutant binding assays\",\n      \"pmids\": [\"12923056\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not map specificity onto in vivo genomic occupancy\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Demonstrated PBX1 as an essential hierarchical organ-patterning factor across multiple organ systems, placing it genetically upstream of organ-specific regulators.\",\n      \"evidence\": \"Constitutive and compound-heterozygous mouse knockouts with marker analysis, explant recombination, and glucose-tolerance phenotyping (skeleton, pancreas/Ipf1, adrenal/SF-1, kidney mesenchyme)\",\n      \"pmids\": [\"11566859\", \"11912494\", \"14595835\", \"12591246\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct promoter occupancy at most downstream targets not shown in these studies\", \"Did not distinguish HOX-dependent vs HOX-independent mechanisms per organ\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Established that PBX1/PBX2 act upstream of HOX, Shh, and Polycomb to control limb and axial patterning, demonstrating their hierarchical position above these regulators.\",\n      \"evidence\": \"Pbx1/Pbx2 compound knockout mice with in situ hybridization and molecular markers\",\n      \"pmids\": [\"16672333\", \"18691704\", \"15944191\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of redundancy between PBX1 and PBX2 not fully separated\", \"Direct vs indirect control of Shh/Polycomb not resolved\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Defined PBX1 as a stage-specific hematopoietic regulator required between HSC and common lymphoid progenitor stages, controlling lymphoid potential and restraining myeloid maturation via MEIS1-dependent programs.\",\n      \"evidence\": \"Blastocyst complementation, conditional knockout, rescue, and progenitor profiling\",\n      \"pmids\": [\"17244677\", \"23660001\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct PBX1 target genes in progenitors not fully enumerated\", \"Partner requirements at each stage not dissected\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Discovered PBX1 functions as a pioneer factor that opens chromatin and guides ERα recruitment, redefining it from a passive HOX cofactor to a primary determinant of chromatin accessibility and the estrogen transcriptional response.\",\n      \"evidence\": \"ChIP-seq, FAIRE-seq, and shRNA knockdown with expression profiling in breast cancer cells\",\n      \"pmids\": [\"22125492\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Determinants of locus selection by PBX1 not fully defined\", \"Whether pioneer activity requires partner proteins not resolved here\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Showed PBX1 can be oncogene or tumor suppressor depending on partner choice, because PREP1 sequesters PBX1 from MEIS1 and destabilizes MEIS1, linking partner competition to transformation.\",\n      \"evidence\": \"Co-IP, protein-stability assays, and transformation assays in mouse embryonic fibroblasts\",\n      \"pmids\": [\"24578510\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab biochemistry\", \"Quantitative thresholds of partner availability in vivo unknown\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Established direct PBX1 transcriptional control of lineage-specifying genes across diverse contexts (NK cells, dopaminergic neurons, SVZ neurogenesis, T-cell tolerance), including occupancy of regulatory regions before target expression consistent with a priming role.\",\n      \"evidence\": \"Conditional knockouts, transgenics, and ChIP at Nfil3, Pitx3/Onecut2/Nfe2l1, Dcx/Th, and CD44 with human PD tissue analysis\",\n      \"pmids\": [\"27354364\", \"27226325\", \"32190943\", \"27296664\", \"28257976\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of temporal priming not biochemically defined\", \"Most targets validated in single systems\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Defined the E2A-PBX1 leukemic transcription mechanism as RUNX1-dependent chromatin tethering coupled to coactivator recruitment, rather than dependence on the PBX1 homeodomain DNA-binding activity.\",\n      \"evidence\": \"ChIP-seq, reciprocal co-IP, CRISPR/mutagenesis, and transformation assays defining RUNX1, p300/CBP (PCET/KIX), and MED1/Mediator dependence\",\n      \"pmids\": [\"32276273\", \"33542097\", \"22972988\", \"23044487\", \"29694893\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry of the multi-factor enhancer complex not resolved\", \"Whether wild-type PBX1 uses analogous coactivator recruitment unclear\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Explained how a ubiquitous factor achieves tissue specificity: tissue-restricted partners such as HAND2 occupy subsets of PBX1-bound regions to channel PBX1 into limb-specific gene regulatory networks.\",\n      \"evidence\": \"Tissue-specific/temporal knockout with genome-wide PBX1 binding across multiple tissues, ATAC-seq, and interaction assays\",\n      \"pmids\": [\"37414772\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Generality of partner-restricted targeting beyond limb not tested\", \"Direct structural basis of HAND2-PBX1 contact not shown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identified the post-translational control of PBX1 abundance as a tunable opposing pair of enzymes, linking ubiquitin homeostasis to PBX1-driven transcriptional output.\",\n      \"evidence\": \"Co-IP/AP-MS, ubiquitination assays, domain deletion, and pharmacological inhibition (USP9x stabilizing; TRIM26 K48-degrading)\",\n      \"pmids\": [\"30718275\", \"37324936\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Upstream signals controlling USP9x/TRIM26 activity on PBX1 unknown\", \"Modification sites on PBX1 not mapped\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How wild-type PBX1 pioneer activity, partner-dictated locus selection, and post-translational stability are integrated to produce context-specific transcriptional outputs in vivo remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model linking chromatin opening to partner choice\", \"Determinants of genome-wide site selection by free PBX1 undefined\", \"Therapeutic targeting of the PBX1-DNA interface remains early-stage\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 3, 4, 5, 9]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [22, 28, 29, 35, 47]},\n      {\"term_id\": \"GO:0003700\", \"supporting_discovery_ids\": [22, 35]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [41]},\n      {\"term_id\": \"GO:0005654\", \"supporting_discovery_ids\": [22, 37]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [22, 35, 37, 45]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [11, 12, 13, 14, 16]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [22, 32]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [10, 37, 38, 41]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [18, 35, 44]}\n    ],\n    \"complexes\": [\"PBX1-HOX heterodimer\", \"PREP1/MEIS1-PBX1-HOX ternary complex\"],\n    \"partners\": [\"HOXB1\", \"HOXA9\", \"MEIS1\", \"PREP1/PKNOX1\", \"RUNX1\", \"HAND2\", \"USP9x\", \"TRIM26\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":9,"faith_total":9,"faith_pct":100.0}}